| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Lab-On-A-Chip Devices | 53 | 2024 | 445 | 16.150 |
Why?
|
| Cytoskeleton | 69 | 2014 | 1179 | 6.120 |
Why?
|
| Microfluidic Analytical Techniques | 27 | 2019 | 820 | 5.970 |
Why?
|
| Mechanotransduction, Cellular | 31 | 2023 | 541 | 5.810 |
Why?
|
| Microfluidics | 22 | 2022 | 672 | 5.610 |
Why?
|
| Extracellular Matrix | 65 | 2019 | 1738 | 4.540 |
Why?
|
| Cell Culture Techniques | 25 | 2022 | 1667 | 3.910 |
Why?
|
| Stress, Mechanical | 57 | 2021 | 1676 | 3.310 |
Why?
|
| Biosensing Techniques | 8 | 2024 | 662 | 3.240 |
Why?
|
| Models, Biological | 57 | 2024 | 9495 | 3.020 |
Why?
|
| Endothelial Cells | 43 | 2024 | 3589 | 2.620 |
Why?
|
| Cell Adhesion | 65 | 2020 | 3096 | 2.570 |
Why?
|
| Biofouling | 5 | 2024 | 8 | 2.550 |
Why?
|
| Organ Culture Techniques | 9 | 2021 | 794 | 2.520 |
Why?
|
| Focal Adhesions | 16 | 2014 | 113 | 2.200 |
Why?
|
| Endothelium, Vascular | 61 | 2020 | 4427 | 2.170 |
Why?
|
| Cell Physiological Phenomena | 13 | 2014 | 152 | 1.980 |
Why?
|
| Tissue Engineering | 16 | 2018 | 1893 | 1.950 |
Why?
|
| Integrins | 26 | 2008 | 842 | 1.780 |
Why?
|
| Cells, Cultured | 91 | 2021 | 19015 | 1.730 |
Why?
|
| Intestinal Mucosa | 10 | 2022 | 3044 | 1.690 |
Why?
|
| rho GTP-Binding Proteins | 9 | 2020 | 279 | 1.670 |
Why?
|
| Cell Size | 28 | 2008 | 626 | 1.660 |
Why?
|
| Mucus | 4 | 2024 | 346 | 1.620 |
Why?
|
| Animals | 245 | 2024 | 169246 | 1.600 |
Why?
|
| Biomimetics | 5 | 2020 | 172 | 1.600 |
Why?
|
| TRPV Cation Channels | 5 | 2022 | 244 | 1.550 |
Why?
|
| Mesoderm | 5 | 2015 | 679 | 1.550 |
Why?
|
| Capillaries | 30 | 2024 | 755 | 1.520 |
Why?
|
| Biomimetic Materials | 8 | 2014 | 173 | 1.510 |
Why?
|
| Electrochemical Techniques | 5 | 2024 | 94 | 1.490 |
Why?
|
| Organoids | 4 | 2024 | 743 | 1.470 |
Why?
|
| Magnetics | 11 | 2014 | 597 | 1.460 |
Why?
|
| Cell Shape | 13 | 2015 | 371 | 1.390 |
Why?
|
| Cell Movement | 25 | 2014 | 5210 | 1.370 |
Why?
|
| Cattle | 54 | 2015 | 3819 | 1.360 |
Why?
|
| Pseudopodia | 7 | 2012 | 167 | 1.330 |
Why?
|
| Thrombosis | 8 | 2019 | 2957 | 1.300 |
Why?
|
| Gamma Rays | 3 | 2023 | 319 | 1.210 |
Why?
|
| Drug Delivery Systems | 7 | 2021 | 2232 | 1.210 |
Why?
|
| Nanoparticles | 9 | 2024 | 1985 | 1.200 |
Why?
|
| Embryonic Development | 7 | 2018 | 724 | 1.200 |
Why?
|
| Mannose-Binding Lectin | 3 | 2019 | 146 | 1.180 |
Why?
|
| Neovascularization, Physiologic | 12 | 2024 | 1369 | 1.180 |
Why?
|
| Fibronectins | 23 | 2013 | 722 | 1.180 |
Why?
|
| Morphogenesis | 13 | 2013 | 746 | 1.180 |
Why?
|
| Lung | 18 | 2023 | 10099 | 1.170 |
Why?
|
| Mammary Glands, Animal | 3 | 2013 | 273 | 1.170 |
Why?
|
| Pharmaceutical Preparations | 4 | 2021 | 1088 | 1.150 |
Why?
|
| Caco-2 Cells | 10 | 2024 | 366 | 1.140 |
Why?
|
| Pericytes | 3 | 2020 | 299 | 1.130 |
Why?
|
| Emulsions | 2 | 2024 | 150 | 1.130 |
Why?
|
| Embryo, Mammalian | 5 | 2018 | 1676 | 1.090 |
Why?
|
| Hematopoiesis | 6 | 2022 | 2059 | 1.090 |
Why?
|
| Developmental Biology | 3 | 2018 | 79 | 1.090 |
Why?
|
| Signal Transduction | 48 | 2018 | 23645 | 1.080 |
Why?
|
| Nanotechnology | 7 | 2018 | 714 | 1.080 |
Why?
|
| Blood-Brain Barrier | 7 | 2021 | 1034 | 1.070 |
Why?
|
| Biophysics | 7 | 2023 | 379 | 1.070 |
Why?
|
| Cell Differentiation | 30 | 2024 | 11669 | 1.070 |
Why?
|
| Nanocomposites | 2 | 2024 | 53 | 1.070 |
Why?
|
| Malnutrition | 2 | 2023 | 632 | 1.060 |
Why?
|
| Bacteria | 6 | 2021 | 2216 | 1.050 |
Why?
|
| Paxillin | 6 | 2014 | 86 | 1.050 |
Why?
|
| Nanostructures | 4 | 2022 | 553 | 1.040 |
Why?
|
| Fibrinolytic Agents | 4 | 2017 | 2080 | 1.020 |
Why?
|
| Biomedical Engineering | 7 | 2014 | 286 | 1.010 |
Why?
|
| Blood Coagulation Tests | 2 | 2017 | 270 | 0.990 |
Why?
|
| Cytological Techniques | 7 | 2018 | 217 | 0.980 |
Why?
|
| Epithelium | 10 | 2024 | 1607 | 0.980 |
Why?
|
| Tensile Strength | 6 | 2016 | 332 | 0.970 |
Why?
|
| Robotics | 3 | 2020 | 812 | 0.930 |
Why?
|
| Extracorporeal Circulation | 2 | 2015 | 181 | 0.930 |
Why?
|
| Tooth | 4 | 2014 | 210 | 0.920 |
Why?
|
| Extracellular Fluid | 2 | 2024 | 165 | 0.920 |
Why?
|
| Colon | 3 | 2022 | 1801 | 0.910 |
Why?
|
| Dimethylpolysiloxanes | 8 | 2021 | 143 | 0.900 |
Why?
|
| Epithelial Cells | 14 | 2021 | 3703 | 0.900 |
Why?
|
| Neovascularization, Pathologic | 19 | 2015 | 2631 | 0.900 |
Why?
|
| Cell Division | 32 | 2008 | 4473 | 0.890 |
Why?
|
| Sulfadoxine | 1 | 2023 | 47 | 0.890 |
Why?
|
| Humans | 223 | 2024 | 768166 | 0.890 |
Why?
|
| Extracellular Matrix Proteins | 7 | 2015 | 832 | 0.880 |
Why?
|
| Odontogenesis | 2 | 2015 | 65 | 0.870 |
Why?
|
| Pregnancy Complications, Parasitic | 1 | 2023 | 65 | 0.870 |
Why?
|
| Radiation Injuries | 2 | 2023 | 1198 | 0.870 |
Why?
|
| Pulmonary Alveoli | 4 | 2021 | 665 | 0.870 |
Why?
|
| Immunomagnetic Separation | 3 | 2014 | 78 | 0.850 |
Why?
|
| Chitosan | 2 | 2016 | 141 | 0.840 |
Why?
|
| Artificial Organs | 2 | 2014 | 149 | 0.840 |
Why?
|
| Blood-Borne Pathogens | 2 | 2015 | 52 | 0.830 |
Why?
|
| Intestines | 6 | 2024 | 1909 | 0.830 |
Why?
|
| Serum Albumin, Bovine | 2 | 2022 | 320 | 0.820 |
Why?
|
| Pharmacokinetics | 2 | 2020 | 86 | 0.820 |
Why?
|
| Larva | 1 | 2024 | 515 | 0.820 |
Why?
|
| Bone Marrow | 3 | 2020 | 2935 | 0.810 |
Why?
|
| Influenza, Human | 3 | 2022 | 1541 | 0.800 |
Why?
|
| Hemofiltration | 2 | 2015 | 58 | 0.800 |
Why?
|
| rac GTP-Binding Proteins | 4 | 2011 | 163 | 0.800 |
Why?
|
| Vinculin | 8 | 2014 | 59 | 0.790 |
Why?
|
| Intestine, Small | 3 | 2022 | 1217 | 0.790 |
Why?
|
| Gram-Positive Bacteria | 2 | 2022 | 179 | 0.790 |
Why?
|
| Mechanoreceptors | 5 | 2008 | 194 | 0.790 |
Why?
|
| Mammary Neoplasms, Experimental | 3 | 2014 | 506 | 0.780 |
Why?
|
| Blood-Air Barrier | 3 | 2017 | 24 | 0.770 |
Why?
|
| Immunity, Innate | 3 | 2024 | 3080 | 0.760 |
Why?
|
| Actins | 21 | 2020 | 2064 | 0.760 |
Why?
|
| Stress Fibers | 5 | 2008 | 55 | 0.750 |
Why?
|
| Intestinal Diseases | 2 | 2024 | 505 | 0.750 |
Why?
|
| Vagina | 2 | 2024 | 850 | 0.740 |
Why?
|
| Fluorescence Recovery After Photobleaching | 5 | 2008 | 54 | 0.730 |
Why?
|
| Nanocapsules | 2 | 2012 | 95 | 0.730 |
Why?
|
| Mice | 83 | 2024 | 82029 | 0.730 |
Why?
|
| Organ Preservation | 1 | 2024 | 393 | 0.730 |
Why?
|
| Microspheres | 10 | 2016 | 788 | 0.720 |
Why?
|
| Vaginosis, Bacterial | 1 | 2022 | 154 | 0.720 |
Why?
|
| Cell Nucleus | 12 | 2009 | 2885 | 0.720 |
Why?
|
| Equipment Design | 10 | 2024 | 3522 | 0.720 |
Why?
|
| Rheology | 4 | 2009 | 348 | 0.710 |
Why?
|
| Mitogen-Activated Protein Kinases | 2 | 2022 | 1245 | 0.700 |
Why?
|
| Cervix Uteri | 1 | 2024 | 577 | 0.700 |
Why?
|
| Xenopus laevis | 1 | 2024 | 967 | 0.690 |
Why?
|
| Tissue Scaffolds | 3 | 2017 | 951 | 0.680 |
Why?
|
| Pulmonary Edema | 2 | 2013 | 408 | 0.670 |
Why?
|
| Mesenchymal Stem Cells | 5 | 2020 | 1672 | 0.670 |
Why?
|
| Microtechnology | 3 | 2019 | 70 | 0.670 |
Why?
|
| Acute Lung Injury | 1 | 2023 | 377 | 0.670 |
Why?
|
| Cells | 5 | 2019 | 166 | 0.660 |
Why?
|
| Inhalation | 1 | 2020 | 145 | 0.660 |
Why?
|
| Blood Platelets | 5 | 2019 | 2479 | 0.650 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2022 | 567 | 0.650 |
Why?
|
| Enterohemorrhagic Escherichia coli | 1 | 2019 | 20 | 0.650 |
Why?
|
| Drug Discovery | 4 | 2024 | 1068 | 0.640 |
Why?
|
| Methamphetamine | 2 | 2020 | 167 | 0.640 |
Why?
|
| Nanotubes, Carbon | 1 | 2019 | 72 | 0.640 |
Why?
|
| Neoplasms | 16 | 2019 | 22371 | 0.640 |
Why?
|
| Podocytes | 3 | 2020 | 403 | 0.630 |
Why?
|
| Lung Injury | 1 | 2023 | 433 | 0.630 |
Why?
|
| Protein-Lysine 6-Oxidase | 3 | 2015 | 56 | 0.620 |
Why?
|
| Opsonin Proteins | 2 | 2015 | 144 | 0.620 |
Why?
|
| Symbiosis | 1 | 2021 | 297 | 0.610 |
Why?
|
| Microvessels | 3 | 2019 | 585 | 0.610 |
Why?
|
| Amino Acids, Dicarboxylic | 1 | 2018 | 23 | 0.610 |
Why?
|
| Gold | 5 | 2019 | 488 | 0.600 |
Why?
|
| Influenza A virus | 1 | 2021 | 460 | 0.590 |
Why?
|
| Radiation-Protective Agents | 1 | 2018 | 88 | 0.580 |
Why?
|
| Coated Materials, Biocompatible | 3 | 2017 | 311 | 0.580 |
Why?
|
| Oxygen | 4 | 2024 | 4270 | 0.580 |
Why?
|
| Cell Polarity | 2 | 2012 | 639 | 0.580 |
Why?
|
| Dentin | 1 | 2017 | 75 | 0.580 |
Why?
|
| Antiviral Agents | 5 | 2023 | 3073 | 0.570 |
Why?
|
| Immunoassay | 3 | 2022 | 746 | 0.570 |
Why?
|
| Cell Proliferation | 15 | 2020 | 10474 | 0.560 |
Why?
|
| Enterovirus B, Human | 1 | 2017 | 49 | 0.550 |
Why?
|
| Nylons | 1 | 2016 | 46 | 0.550 |
Why?
|
| Antimalarials | 1 | 2023 | 909 | 0.550 |
Why?
|
| Microtubules | 12 | 2009 | 1064 | 0.550 |
Why?
|
| Capillary Permeability | 4 | 2016 | 772 | 0.540 |
Why?
|
| Antibodies | 7 | 2024 | 2421 | 0.540 |
Why?
|
| Electric Impedance | 3 | 2017 | 794 | 0.540 |
Why?
|
| Drug Evaluation, Preclinical | 3 | 2020 | 1338 | 0.530 |
Why?
|
| Drug Resistance, Viral | 1 | 2021 | 869 | 0.530 |
Why?
|
| Molecular Biology | 2 | 2019 | 573 | 0.520 |
Why?
|
| Tissue Culture Techniques | 2 | 2015 | 290 | 0.520 |
Why?
|
| Liver | 14 | 2024 | 7577 | 0.520 |
Why?
|
| Fibroblasts | 13 | 2021 | 4176 | 0.520 |
Why?
|
| Embryo, Nonmammalian | 2 | 2020 | 910 | 0.520 |
Why?
|
| Peristalsis | 1 | 2015 | 60 | 0.510 |
Why?
|
| Lung Diseases | 2 | 2017 | 1944 | 0.510 |
Why?
|
| Hematopoietic Stem Cells | 4 | 2020 | 3409 | 0.510 |
Why?
|
| Kidney Glomerulus | 1 | 2018 | 570 | 0.510 |
Why?
|
| Porosity | 4 | 2024 | 352 | 0.510 |
Why?
|
| Transglutaminases | 1 | 2016 | 200 | 0.500 |
Why?
|
| Sepsis | 5 | 2022 | 2608 | 0.500 |
Why?
|
| Collagen Type VI | 1 | 2015 | 26 | 0.500 |
Why?
|
| Astrocytes | 3 | 2020 | 1350 | 0.490 |
Why?
|
| Molecular Motor Proteins | 2 | 2014 | 106 | 0.490 |
Why?
|
| Metal Nanoparticles | 1 | 2019 | 406 | 0.490 |
Why?
|
| Acrylic Resins | 2 | 2014 | 135 | 0.490 |
Why?
|
| Tissue Adhesives | 1 | 2016 | 177 | 0.480 |
Why?
|
| Coculture Techniques | 5 | 2024 | 1340 | 0.480 |
Why?
|
| Escherichia coli Infections | 1 | 2019 | 524 | 0.480 |
Why?
|
| Sterilization | 1 | 2015 | 132 | 0.470 |
Why?
|
| Basement Membrane | 10 | 2006 | 348 | 0.470 |
Why?
|
| Microscopy, Fluorescence | 12 | 2017 | 2633 | 0.470 |
Why?
|
| Molar | 1 | 2015 | 155 | 0.460 |
Why?
|
| Influenza Vaccines | 1 | 2022 | 781 | 0.460 |
Why?
|
| Respiratory Mucosa | 1 | 2017 | 439 | 0.450 |
Why?
|
| Connective Tissue | 2 | 2007 | 425 | 0.450 |
Why?
|
| Staphylococcus aureus | 4 | 2016 | 1430 | 0.450 |
Why?
|
| Immunoglobulin Fc Fragments | 1 | 2016 | 287 | 0.450 |
Why?
|
| Cell Aggregation | 2 | 2013 | 238 | 0.450 |
Why?
|
| Antigens, Neoplasm | 1 | 2022 | 1997 | 0.450 |
Why?
|
| Compressive Strength | 2 | 2014 | 159 | 0.450 |
Why?
|
| Biglycan | 1 | 2013 | 10 | 0.450 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2016 | 858 | 0.450 |
Why?
|
| Animal Testing Alternatives | 3 | 2020 | 15 | 0.450 |
Why?
|
| Magnetite Nanoparticles | 1 | 2015 | 312 | 0.440 |
Why?
|
| Elasticity | 9 | 2015 | 656 | 0.440 |
Why?
|
| Evolution, Molecular | 2 | 2021 | 1896 | 0.440 |
Why?
|
| Neutrophils | 4 | 2022 | 3786 | 0.440 |
Why?
|
| Induced Pluripotent Stem Cells | 3 | 2024 | 1887 | 0.440 |
Why?
|
| Apoptosis | 14 | 2018 | 9523 | 0.440 |
Why?
|
| Menstrual Cycle | 1 | 2017 | 546 | 0.440 |
Why?
|
| Transcription, Genetic | 7 | 2018 | 7608 | 0.430 |
Why?
|
| Interleukin-13 | 1 | 2015 | 390 | 0.430 |
Why?
|
| rhoA GTP-Binding Protein | 4 | 2011 | 235 | 0.430 |
Why?
|
| Accreditation | 1 | 2016 | 476 | 0.430 |
Why?
|
| Staphylococcal Infections | 1 | 2022 | 1398 | 0.420 |
Why?
|
| Metabolome | 1 | 2020 | 1009 | 0.420 |
Why?
|
| RNA, Small Interfering | 7 | 2020 | 3428 | 0.420 |
Why?
|
| Swine | 8 | 2024 | 5995 | 0.420 |
Why?
|
| Kinetics | 17 | 2010 | 6329 | 0.420 |
Why?
|
| Electrodes | 3 | 2022 | 617 | 0.420 |
Why?
|
| Hemostasis | 1 | 2016 | 468 | 0.420 |
Why?
|
| Drug Design | 6 | 2020 | 1046 | 0.420 |
Why?
|
| Polyurethanes | 1 | 2013 | 110 | 0.420 |
Why?
|
| Bronchopulmonary Dysplasia | 2 | 2013 | 329 | 0.410 |
Why?
|
| Models, Theoretical | 5 | 2015 | 3573 | 0.410 |
Why?
|
| Integumentary System | 1 | 2011 | 2 | 0.400 |
Why?
|
| Bone Marrow Cells | 1 | 2020 | 2414 | 0.400 |
Why?
|
| Cystic Fibrosis | 1 | 2021 | 1294 | 0.400 |
Why?
|
| Cell Separation | 3 | 2015 | 1728 | 0.400 |
Why?
|
| Molecular Imaging | 1 | 2019 | 826 | 0.390 |
Why?
|
| Mesenteric Vascular Occlusion | 1 | 2012 | 93 | 0.390 |
Why?
|
| Contractile Proteins | 3 | 2010 | 240 | 0.390 |
Why?
|
| Retinopathy of Prematurity | 2 | 2013 | 450 | 0.380 |
Why?
|
| Pathology | 1 | 2015 | 270 | 0.380 |
Why?
|
| Bacterial Infections | 2 | 2021 | 1397 | 0.380 |
Why?
|
| Vascular Endothelial Growth Factor A | 9 | 2015 | 3514 | 0.380 |
Why?
|
| Myeloid Cells | 2 | 2016 | 839 | 0.380 |
Why?
|
| Fibroblast Growth Factor 8 | 1 | 2011 | 62 | 0.380 |
Why?
|
| Fibroins | 1 | 2011 | 59 | 0.380 |
Why?
|
| Cyclic AMP | 4 | 2015 | 1470 | 0.380 |
Why?
|
| Anti-Bacterial Agents | 4 | 2019 | 7477 | 0.380 |
Why?
|
| Polymers | 7 | 2017 | 1630 | 0.380 |
Why?
|
| Kidney Tubules, Proximal | 1 | 2013 | 386 | 0.370 |
Why?
|
| Surface Properties | 8 | 2014 | 1166 | 0.370 |
Why?
|
| Tumor Microenvironment | 5 | 2024 | 3948 | 0.370 |
Why?
|
| Cell Membrane | 14 | 2012 | 3655 | 0.360 |
Why?
|
| Infant, Premature, Diseases | 2 | 2013 | 712 | 0.360 |
Why?
|
| Organ Transplantation | 1 | 2021 | 1176 | 0.360 |
Why?
|
| Anaerobiosis | 2 | 2022 | 140 | 0.360 |
Why?
|
| Chromosomes | 3 | 1998 | 578 | 0.360 |
Why?
|
| Transcription Factors | 6 | 2024 | 12168 | 0.360 |
Why?
|
| Rats, Wistar | 7 | 2016 | 1888 | 0.360 |
Why?
|
| Mechanical Phenomena | 1 | 2011 | 143 | 0.350 |
Why?
|
| Gene Expression Regulation, Developmental | 4 | 2015 | 3610 | 0.350 |
Why?
|
| NIH 3T3 Cells | 6 | 2008 | 669 | 0.350 |
Why?
|
| Proteome | 1 | 2020 | 1890 | 0.350 |
Why?
|
| Candida albicans | 2 | 2014 | 375 | 0.340 |
Why?
|
| Receptors, Cell Surface | 7 | 2019 | 2819 | 0.340 |
Why?
|
| PAX9 Transcription Factor | 3 | 2015 | 14 | 0.340 |
Why?
|
| Myosin Light Chains | 4 | 2007 | 122 | 0.340 |
Why?
|
| Cytoskeletal Proteins | 7 | 2006 | 1327 | 0.340 |
Why?
|
| Fibrin | 2 | 2016 | 514 | 0.330 |
Why?
|
| Muscle, Smooth, Vascular | 5 | 2008 | 1493 | 0.330 |
Why?
|
| Cell Cycle | 10 | 2014 | 2932 | 0.330 |
Why?
|
| Micro-Electrical-Mechanical Systems | 1 | 2009 | 30 | 0.320 |
Why?
|
| Gene Expression Regulation, Neoplastic | 8 | 2015 | 8647 | 0.320 |
Why?
|
| G-Protein-Coupled Receptor Kinase 1 | 1 | 2008 | 7 | 0.320 |
Why?
|
| Cell Line | 14 | 2021 | 15597 | 0.320 |
Why?
|
| Academies and Institutes | 1 | 2011 | 326 | 0.310 |
Why?
|
| Temperature | 2 | 2014 | 2234 | 0.310 |
Why?
|
| Paired Box Transcription Factors | 3 | 2015 | 206 | 0.310 |
Why?
|
| Microchip Analytical Procedures | 2 | 2019 | 29 | 0.310 |
Why?
|
| Cell Cycle Proteins | 6 | 2020 | 3445 | 0.310 |
Why?
|
| Adaptation, Physiological | 2 | 2006 | 1312 | 0.310 |
Why?
|
| Rho Factor | 1 | 2008 | 8 | 0.310 |
Why?
|
| Green Fluorescent Proteins | 6 | 2021 | 2065 | 0.310 |
Why?
|
| GTP-Binding Protein alpha Subunits | 1 | 2009 | 103 | 0.300 |
Why?
|
| Spleen | 1 | 2014 | 2295 | 0.300 |
Why?
|
| Protein Multimerization | 1 | 2013 | 965 | 0.300 |
Why?
|
| Image Processing, Computer-Assisted | 4 | 2019 | 9015 | 0.300 |
Why?
|
| Microfilament Proteins | 3 | 2010 | 1133 | 0.300 |
Why?
|
| Gene Silencing | 2 | 2014 | 1505 | 0.300 |
Why?
|
| Permeability | 4 | 2019 | 725 | 0.300 |
Why?
|
| Blood Component Removal | 1 | 2009 | 132 | 0.290 |
Why?
|
| Plasma | 2 | 2022 | 585 | 0.290 |
Why?
|
| Lasers | 4 | 2007 | 952 | 0.290 |
Why?
|
| Particle Size | 3 | 2024 | 1649 | 0.280 |
Why?
|
| Paper | 3 | 2013 | 83 | 0.280 |
Why?
|
| Actinin | 4 | 2020 | 165 | 0.280 |
Why?
|
| Calibration | 3 | 2020 | 819 | 0.280 |
Why?
|
| Cricetinae | 4 | 2021 | 2423 | 0.280 |
Why?
|
| Biocompatible Materials | 7 | 2021 | 1702 | 0.280 |
Why?
|
| Escherichia coli | 5 | 2021 | 4214 | 0.280 |
Why?
|
| Infant, Premature | 2 | 2013 | 2124 | 0.280 |
Why?
|
| Disinfection | 1 | 2009 | 207 | 0.270 |
Why?
|
| Regenerative Medicine | 2 | 2007 | 313 | 0.270 |
Why?
|
| Antibodies, Viral | 3 | 2022 | 3216 | 0.270 |
Why?
|
| Guanine Nucleotide Exchange Factors | 2 | 2009 | 572 | 0.270 |
Why?
|
| Tissue Plasminogen Activator | 1 | 2012 | 1165 | 0.270 |
Why?
|
| Heart-Assist Devices | 1 | 2017 | 1292 | 0.260 |
Why?
|
| Islets of Langerhans | 3 | 2011 | 1351 | 0.260 |
Why?
|
| Shear Strength | 3 | 2016 | 160 | 0.260 |
Why?
|
| Cell Line, Tumor | 13 | 2019 | 17140 | 0.260 |
Why?
|
| Integrin alpha3 | 1 | 2005 | 26 | 0.260 |
Why?
|
| Kidney | 7 | 2021 | 7064 | 0.260 |
Why?
|
| Models, Animal | 2 | 2024 | 2120 | 0.260 |
Why?
|
| Integrin alpha6 | 1 | 2005 | 30 | 0.260 |
Why?
|
| Organogenesis | 3 | 2012 | 214 | 0.260 |
Why?
|
| Aging | 3 | 2017 | 8744 | 0.250 |
Why?
|
| Immunomodulation | 1 | 2009 | 549 | 0.250 |
Why?
|
| Interleukin-2 | 1 | 2012 | 1895 | 0.250 |
Why?
|
| Proteins | 6 | 2021 | 6009 | 0.250 |
Why?
|
| Membrane Microdomains | 1 | 2007 | 205 | 0.250 |
Why?
|
| Dinoprostone | 3 | 2019 | 597 | 0.250 |
Why?
|
| Calmodulin-Binding Proteins | 2 | 2006 | 238 | 0.250 |
Why?
|
| Awards and Prizes | 1 | 2010 | 365 | 0.250 |
Why?
|
| Flow Cytometry | 3 | 2015 | 5902 | 0.250 |
Why?
|
| Smoking | 2 | 2020 | 9092 | 0.250 |
Why?
|
| Collagen | 9 | 2016 | 2643 | 0.250 |
Why?
|
| Respiration, Artificial | 2 | 2013 | 2726 | 0.250 |
Why?
|
| Oligopeptides | 9 | 2014 | 1194 | 0.250 |
Why?
|
| Neoplastic Cells, Circulating | 1 | 2012 | 952 | 0.240 |
Why?
|
| Biological Clocks | 1 | 2007 | 321 | 0.240 |
Why?
|
| Polyglycolic Acid | 3 | 2017 | 408 | 0.240 |
Why?
|
| Point-of-Care Systems | 3 | 2021 | 1238 | 0.240 |
Why?
|
| Neurons | 3 | 2020 | 9514 | 0.240 |
Why?
|
| Hemorrhage | 1 | 2017 | 3467 | 0.240 |
Why?
|
| Calcium | 4 | 2007 | 5792 | 0.240 |
Why?
|
| Receptors, Opioid, delta | 1 | 2024 | 48 | 0.230 |
Why?
|
| Environmental Exposure | 1 | 2020 | 4543 | 0.230 |
Why?
|
| Gardnerella vaginalis | 1 | 2024 | 20 | 0.230 |
Why?
|
| Physical Therapy Modalities | 1 | 2008 | 533 | 0.230 |
Why?
|
| Cytochalasin D | 5 | 2006 | 91 | 0.230 |
Why?
|
| Rats | 23 | 2019 | 23760 | 0.230 |
Why?
|
| Homeodomain Proteins | 1 | 2014 | 2429 | 0.230 |
Why?
|
| Models, Molecular | 5 | 2019 | 5403 | 0.230 |
Why?
|
| Platelet Aggregation | 2 | 2019 | 769 | 0.230 |
Why?
|
| S-Phase Kinase-Associated Proteins | 1 | 2004 | 89 | 0.230 |
Why?
|
| Platelet-Derived Growth Factor | 4 | 2012 | 617 | 0.220 |
Why?
|
| Regeneration | 5 | 2021 | 1524 | 0.220 |
Why?
|
| Antimicrobial Cationic Peptides | 2 | 2016 | 352 | 0.220 |
Why?
|
| Pyrimethamine | 1 | 2023 | 95 | 0.220 |
Why?
|
| Biology | 2 | 2003 | 292 | 0.220 |
Why?
|
| Leukocytes, Mononuclear | 3 | 2023 | 1854 | 0.220 |
Why?
|
| Nonlinear Dynamics | 1 | 2006 | 493 | 0.210 |
Why?
|
| Electromagnetic Fields | 1 | 2005 | 289 | 0.210 |
Why?
|
| Granulocyte Colony-Stimulating Factor | 2 | 2016 | 631 | 0.210 |
Why?
|
| Tumor Suppressor Proteins | 3 | 2004 | 2810 | 0.210 |
Why?
|
| Cell Transformation, Neoplastic | 3 | 2013 | 2846 | 0.210 |
Why?
|
| Sturge-Weber Syndrome | 1 | 2024 | 89 | 0.210 |
Why?
|
| Gene Expression Profiling | 7 | 2015 | 9538 | 0.210 |
Why?
|
| Nocodazole | 5 | 2004 | 95 | 0.210 |
Why?
|
| Protein Binding | 7 | 2020 | 9343 | 0.210 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 3 | 2011 | 3800 | 0.200 |
Why?
|
| Drug Combinations | 2 | 2023 | 2089 | 0.200 |
Why?
|
| Xenopus | 1 | 2024 | 711 | 0.200 |
Why?
|
| TRPP Cation Channels | 4 | 2008 | 177 | 0.200 |
Why?
|
| Database Management Systems | 1 | 2003 | 263 | 0.200 |
Why?
|
| Heart | 3 | 2021 | 4446 | 0.200 |
Why?
|
| Cisplatin | 3 | 2020 | 1660 | 0.200 |
Why?
|
| RNA, Messenger | 6 | 2017 | 12800 | 0.200 |
Why?
|
| DNA | 8 | 2018 | 7214 | 0.200 |
Why?
|
| Neoplasm Metastasis | 5 | 2019 | 4912 | 0.200 |
Why?
|
| Inflammation | 4 | 2021 | 10873 | 0.200 |
Why?
|
| Doxycycline | 1 | 2024 | 349 | 0.200 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 2 | 2013 | 393 | 0.200 |
Why?
|
| Benzamidines | 1 | 2021 | 20 | 0.200 |
Why?
|
| Recombinant Fusion Proteins | 5 | 2016 | 3740 | 0.190 |
Why?
|
| Physarum polycephalum | 1 | 2021 | 2 | 0.190 |
Why?
|
| Female | 28 | 2024 | 397192 | 0.190 |
Why?
|
| DNA Contamination | 1 | 2021 | 19 | 0.190 |
Why?
|
| Fluorescence | 1 | 2004 | 756 | 0.190 |
Why?
|
| Eukaryotic Cells | 1 | 2003 | 192 | 0.190 |
Why?
|
| S Phase | 5 | 2004 | 424 | 0.190 |
Why?
|
| Influenza A Virus, H3N2 Subtype | 1 | 2022 | 85 | 0.190 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2021 | 3814 | 0.190 |
Why?
|
| Proteomics | 3 | 2023 | 3912 | 0.190 |
Why?
|
| Phosphorylation | 13 | 2020 | 8317 | 0.190 |
Why?
|
| Computer Graphics | 1 | 2003 | 344 | 0.190 |
Why?
|
| Stem Cells | 3 | 2014 | 3537 | 0.190 |
Why?
|
| Time Factors | 13 | 2016 | 40218 | 0.190 |
Why?
|
| Hydrogels | 4 | 2015 | 744 | 0.190 |
Why?
|
| Cytotoxins | 1 | 2002 | 154 | 0.190 |
Why?
|
| Amantadine | 1 | 2021 | 59 | 0.190 |
Why?
|
| Receptor, TIE-2 | 4 | 2016 | 183 | 0.190 |
Why?
|
| Repressor Proteins | 3 | 2009 | 2982 | 0.190 |
Why?
|
| Selection, Genetic | 2 | 2017 | 877 | 0.190 |
Why?
|
| Cytokines | 3 | 2022 | 7453 | 0.190 |
Why?
|
| Capsules | 2 | 2019 | 193 | 0.190 |
Why?
|
| Clinical Medicine | 1 | 2003 | 145 | 0.190 |
Why?
|
| Immunoglobulin E | 1 | 2007 | 1506 | 0.190 |
Why?
|
| Cilia | 4 | 2008 | 498 | 0.190 |
Why?
|
| Oseltamivir | 1 | 2021 | 76 | 0.190 |
Why?
|
| Endotoxins | 2 | 2014 | 519 | 0.190 |
Why?
|
| Microscopy, Phase-Contrast | 3 | 2013 | 110 | 0.180 |
Why?
|
| Lactic Acid | 3 | 2017 | 1140 | 0.180 |
Why?
|
| Disease | 2 | 2018 | 675 | 0.180 |
Why?
|
| Mice, Transgenic | 8 | 2013 | 9561 | 0.180 |
Why?
|
| Cardiovascular Physiological Phenomena | 1 | 2002 | 241 | 0.180 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2015 | 2442 | 0.180 |
Why?
|
| Ion Channels | 1 | 2006 | 1043 | 0.180 |
Why?
|
| Biological Transport | 3 | 2018 | 2085 | 0.180 |
Why?
|
| Virus Physiological Phenomena | 1 | 2020 | 15 | 0.180 |
Why?
|
| Hematologic Tests | 1 | 2021 | 239 | 0.180 |
Why?
|
| Ionic Liquids | 1 | 2020 | 11 | 0.180 |
Why?
|
| Guanidines | 1 | 2021 | 194 | 0.180 |
Why?
|
| Eicosanoids | 2 | 2013 | 284 | 0.180 |
Why?
|
| Cell Adhesion Molecules | 5 | 2012 | 1613 | 0.180 |
Why?
|
| Cyclin D1 | 2 | 2002 | 453 | 0.180 |
Why?
|
| Mast Cells | 1 | 2007 | 1406 | 0.170 |
Why?
|
| Bacterial Toxins | 2 | 2005 | 922 | 0.170 |
Why?
|
| Ligands | 5 | 2014 | 3284 | 0.170 |
Why?
|
| Animal Welfare | 1 | 2020 | 19 | 0.170 |
Why?
|
| Laminin | 5 | 2011 | 405 | 0.170 |
Why?
|
| Antineoplastic Agents | 5 | 2017 | 13676 | 0.170 |
Why?
|
| Virology | 1 | 2020 | 76 | 0.170 |
Why?
|
| Infusion Pumps | 1 | 2021 | 163 | 0.170 |
Why?
|
| Muscle Contraction | 2 | 2008 | 1209 | 0.170 |
Why?
|
| Klebsiella pneumoniae | 1 | 2022 | 253 | 0.170 |
Why?
|
| Immobilized Proteins | 1 | 2019 | 24 | 0.170 |
Why?
|
| 3T3 Cells | 7 | 2012 | 1084 | 0.170 |
Why?
|
| Mice, Inbred C57BL | 14 | 2018 | 22379 | 0.170 |
Why?
|
| Adsorption | 2 | 2015 | 198 | 0.170 |
Why?
|
| Biochemistry | 1 | 2001 | 116 | 0.170 |
Why?
|
| Asymptomatic Infections | 1 | 2021 | 136 | 0.170 |
Why?
|
| Dendritic Cells | 2 | 2018 | 2747 | 0.170 |
Why?
|
| Lipopolysaccharides | 3 | 2018 | 2219 | 0.170 |
Why?
|
| Body Fluids | 1 | 2021 | 321 | 0.170 |
Why?
|
| Microscopy, Confocal | 5 | 2016 | 1972 | 0.170 |
Why?
|
| Amides | 3 | 2008 | 451 | 0.170 |
Why?
|
| Myocytes, Smooth Muscle | 4 | 2006 | 702 | 0.170 |
Why?
|
| Biological Evolution | 3 | 2017 | 1076 | 0.170 |
Why?
|
| Angiopoietin-1 | 2 | 2012 | 133 | 0.170 |
Why?
|
| Transcytosis | 1 | 2019 | 48 | 0.160 |
Why?
|
| Receptors, Transferrin | 1 | 2021 | 300 | 0.160 |
Why?
|
| Sensation | 1 | 2021 | 336 | 0.160 |
Why?
|
| Disease Progression | 5 | 2019 | 13671 | 0.160 |
Why?
|
| Caproates | 1 | 2019 | 19 | 0.160 |
Why?
|
| RNA, Viral | 3 | 2022 | 2872 | 0.160 |
Why?
|
| G1 Phase | 4 | 2004 | 403 | 0.160 |
Why?
|
| Osmotic Pressure | 1 | 2019 | 137 | 0.160 |
Why?
|
| Bacteroidetes | 1 | 2019 | 84 | 0.160 |
Why?
|
| Mice, Inbred BALB C | 2 | 2019 | 6231 | 0.160 |
Why?
|
| Molecular Sequence Data | 10 | 2014 | 17622 | 0.160 |
Why?
|
| Escherichia coli Proteins | 2 | 2005 | 1058 | 0.160 |
Why?
|
| Cell Membrane Permeability | 2 | 1998 | 571 | 0.160 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 2000 | 327 | 0.160 |
Why?
|
| Dielectric Spectroscopy | 1 | 2019 | 32 | 0.160 |
Why?
|
| Musculoskeletal Physiological Phenomena | 1 | 1999 | 31 | 0.160 |
Why?
|
| Immunosuppressive Agents | 1 | 2011 | 4206 | 0.160 |
Why?
|
| Mannose | 1 | 2019 | 122 | 0.160 |
Why?
|
| Pregnancy | 5 | 2024 | 30256 | 0.160 |
Why?
|
| Histones | 3 | 2006 | 2601 | 0.160 |
Why?
|
| Brain | 5 | 2021 | 27360 | 0.160 |
Why?
|
| Pulmonary Embolism | 1 | 2012 | 2599 | 0.150 |
Why?
|
| Platelet Adhesiveness | 1 | 2019 | 154 | 0.150 |
Why?
|
| Sesquiterpenes | 4 | 1994 | 175 | 0.150 |
Why?
|
| Molecular Weight | 2 | 2019 | 2173 | 0.150 |
Why?
|
| Cystic Fibrosis Transmembrane Conductance Regulator | 1 | 2021 | 453 | 0.150 |
Why?
|
| Breast Neoplasms | 5 | 2019 | 21206 | 0.150 |
Why?
|
| MAP Kinase Signaling System | 3 | 2015 | 1494 | 0.150 |
Why?
|
| Technology | 1 | 2021 | 296 | 0.150 |
Why?
|
| Vascular Malformations | 1 | 2024 | 469 | 0.150 |
Why?
|
| Computer Simulation | 6 | 2021 | 6283 | 0.150 |
Why?
|
| Peptides | 5 | 2013 | 4354 | 0.150 |
Why?
|
| Longevity | 2 | 2017 | 1077 | 0.150 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 2 | 2002 | 1406 | 0.150 |
Why?
|
| Cytoplasm | 7 | 2009 | 1505 | 0.150 |
Why?
|
| Protein Kinase Inhibitors | 3 | 2022 | 5703 | 0.150 |
Why?
|
| Phosphatidylinositol Phosphates | 2 | 1996 | 201 | 0.150 |
Why?
|
| Information Storage and Retrieval | 1 | 2003 | 830 | 0.150 |
Why?
|
| Growth Substances | 4 | 1988 | 759 | 0.150 |
Why?
|
| Caspases | 2 | 2017 | 882 | 0.150 |
Why?
|
| Weightlessness | 1 | 1999 | 103 | 0.150 |
Why?
|
| Species Specificity | 2 | 2019 | 2415 | 0.150 |
Why?
|
| Cell Biology | 1 | 1999 | 92 | 0.150 |
Why?
|
| Adenosine Triphosphate | 2 | 2022 | 2004 | 0.150 |
Why?
|
| DNA Topoisomerases, Type I | 1 | 1998 | 108 | 0.150 |
Why?
|
| Carcinoma, Lewis Lung | 2 | 2015 | 107 | 0.150 |
Why?
|
| Tumor Cells, Cultured | 5 | 2008 | 6124 | 0.150 |
Why?
|
| Disease Models, Animal | 6 | 2022 | 18349 | 0.150 |
Why?
|
| Body Patterning | 3 | 2012 | 634 | 0.140 |
Why?
|
| MSX1 Transcription Factor | 2 | 2014 | 53 | 0.140 |
Why?
|
| Antigens, CD34 | 1 | 2020 | 657 | 0.140 |
Why?
|
| Saliva | 1 | 2022 | 853 | 0.140 |
Why?
|
| DNA Fragmentation | 1 | 2018 | 240 | 0.140 |
Why?
|
| Core Binding Factor Alpha 2 Subunit | 1 | 2020 | 355 | 0.140 |
Why?
|
| Isometric Contraction | 1 | 1998 | 149 | 0.140 |
Why?
|
| Benzoates | 1 | 2019 | 213 | 0.140 |
Why?
|
| Mammals | 2 | 2022 | 1135 | 0.140 |
Why?
|
| Culture Media | 2 | 2017 | 898 | 0.140 |
Why?
|
| Protein Processing, Post-Translational | 4 | 2020 | 1966 | 0.140 |
Why?
|
| Protein Engineering | 1 | 2021 | 553 | 0.140 |
Why?
|
| Cell Lineage | 3 | 2015 | 2575 | 0.140 |
Why?
|
| Virus Internalization | 1 | 2021 | 504 | 0.140 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 2 | 2015 | 481 | 0.140 |
Why?
|
| Fibrinogen | 3 | 2013 | 891 | 0.140 |
Why?
|
| Cytopathogenic Effect, Viral | 1 | 2017 | 152 | 0.140 |
Why?
|
| Receptor, PAR-1 | 1 | 2018 | 109 | 0.140 |
Why?
|
| User-Computer Interface | 1 | 2003 | 1407 | 0.140 |
Why?
|
| Respiration | 2 | 2016 | 1665 | 0.140 |
Why?
|
| Calcium Signaling | 3 | 2015 | 737 | 0.140 |
Why?
|
| Excipients | 1 | 2017 | 96 | 0.140 |
Why?
|
| Heptanoic Acids | 1 | 2019 | 344 | 0.140 |
Why?
|
| Lipid Peroxidation | 1 | 2018 | 276 | 0.140 |
Why?
|
| Endothelium | 4 | 2019 | 768 | 0.140 |
Why?
|
| Glomerulosclerosis, Focal Segmental | 1 | 2020 | 336 | 0.140 |
Why?
|
| Albumins | 3 | 2013 | 577 | 0.140 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p27 | 3 | 2004 | 317 | 0.140 |
Why?
|
| Coxsackievirus Infections | 1 | 2017 | 45 | 0.140 |
Why?
|
| Tumor Necrosis Factor-alpha | 3 | 2020 | 4352 | 0.140 |
Why?
|
| Chromatin | 2 | 2006 | 2981 | 0.140 |
Why?
|
| Carrier Proteins | 3 | 2006 | 4937 | 0.130 |
Why?
|
| Maltose-Binding Proteins | 1 | 2016 | 62 | 0.130 |
Why?
|
| Viscosity | 2 | 2008 | 334 | 0.130 |
Why?
|
| Male | 31 | 2021 | 364719 | 0.130 |
Why?
|
| Goblet Cells | 1 | 2019 | 300 | 0.130 |
Why?
|
| Rare Diseases | 1 | 2022 | 631 | 0.130 |
Why?
|
| Genes, Immediate-Early | 1 | 1996 | 102 | 0.130 |
Why?
|
| Neoplasms, Experimental | 6 | 2011 | 1230 | 0.130 |
Why?
|
| HL-60 Cells | 4 | 2006 | 364 | 0.130 |
Why?
|
| Spheroids, Cellular | 1 | 2018 | 331 | 0.130 |
Why?
|
| Biodiversity | 1 | 2019 | 345 | 0.130 |
Why?
|
| Hydroxychloroquine | 1 | 2020 | 426 | 0.130 |
Why?
|
| Albuminuria | 1 | 2020 | 658 | 0.130 |
Why?
|
| Neuropilin-2 | 2 | 2014 | 55 | 0.130 |
Why?
|
| CD40 Ligand | 1 | 2018 | 528 | 0.130 |
Why?
|
| Estrogen Receptor alpha | 2 | 2013 | 581 | 0.130 |
Why?
|
| Ultrasonics | 1 | 2017 | 208 | 0.130 |
Why?
|
| Microbubbles | 1 | 2017 | 137 | 0.130 |
Why?
|
| Fungi | 1 | 2019 | 345 | 0.130 |
Why?
|
| Epoxy Compounds | 2 | 2013 | 137 | 0.130 |
Why?
|
| Seasons | 1 | 2022 | 1524 | 0.130 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2000 | 1169 | 0.130 |
Why?
|
| Cell Survival | 9 | 2014 | 5777 | 0.130 |
Why?
|
| Gene Regulatory Networks | 2 | 2015 | 1752 | 0.130 |
Why?
|
| Immunotherapy | 1 | 2011 | 4755 | 0.130 |
Why?
|
| Mice, Nude | 2 | 2019 | 3623 | 0.130 |
Why?
|
| Interleukin-6 | 2 | 2016 | 3228 | 0.130 |
Why?
|
| Plicamycin | 1 | 2015 | 12 | 0.130 |
Why?
|
| Ileus | 1 | 2015 | 65 | 0.130 |
Why?
|
| Bacteremia | 1 | 2022 | 986 | 0.130 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2022 | 1967 | 0.130 |
Why?
|
| Wounds and Injuries | 2 | 2005 | 2517 | 0.130 |
Why?
|
| Transfection | 9 | 2016 | 5755 | 0.120 |
Why?
|
| Polycystic Kidney, Autosomal Dominant | 3 | 2008 | 166 | 0.120 |
Why?
|
| Fluorescent Antibody Technique | 6 | 2013 | 2474 | 0.120 |
Why?
|
| Intercellular Junctions | 3 | 2013 | 198 | 0.120 |
Why?
|
| Lectins, C-Type | 1 | 2019 | 594 | 0.120 |
Why?
|
| Birth Weight | 1 | 2023 | 2121 | 0.120 |
Why?
|
| Tight Junctions | 1 | 2018 | 324 | 0.120 |
Why?
|
| rho-Associated Kinases | 3 | 2007 | 290 | 0.120 |
Why?
|
| Rabbits | 2 | 2019 | 4772 | 0.120 |
Why?
|
| Gene Expression Regulation | 8 | 2012 | 11928 | 0.120 |
Why?
|
| Receptors, Fibroblast Growth Factor | 1 | 1995 | 194 | 0.120 |
Why?
|
| Nicotine | 1 | 2020 | 680 | 0.120 |
Why?
|
| Pulmonary Artery | 3 | 2008 | 1946 | 0.120 |
Why?
|
| Organ Specificity | 2 | 2021 | 1968 | 0.120 |
Why?
|
| Microbiological Techniques | 1 | 2015 | 97 | 0.120 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2011 | 4580 | 0.120 |
Why?
|
| Mathematics | 3 | 2006 | 704 | 0.120 |
Why?
|
| Ribosomes | 1 | 1998 | 497 | 0.120 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 1 | 2021 | 704 | 0.120 |
Why?
|
| Shock, Septic | 1 | 2021 | 774 | 0.120 |
Why?
|
| Sp1 Transcription Factor | 1 | 2015 | 143 | 0.120 |
Why?
|
| DNA, Viral | 1 | 2021 | 2204 | 0.120 |
Why?
|
| Sensitivity and Specificity | 2 | 2022 | 14729 | 0.120 |
Why?
|
| Lectins | 2 | 2016 | 490 | 0.120 |
Why?
|
| Muscle Development | 1 | 1996 | 258 | 0.110 |
Why?
|
| Virus Diseases | 1 | 2020 | 724 | 0.110 |
Why?
|
| Tissue Array Analysis | 2 | 2014 | 551 | 0.110 |
Why?
|
| Immunoglobulin Fab Fragments | 1 | 2016 | 446 | 0.110 |
Why?
|
| Platelet Aggregation Inhibitors | 2 | 2016 | 2763 | 0.110 |
Why?
|
| Keratin-14 | 1 | 2013 | 57 | 0.110 |
Why?
|
| Amino Acid Sequence | 8 | 2013 | 13421 | 0.110 |
Why?
|
| Platelet Function Tests | 1 | 2016 | 275 | 0.110 |
Why?
|
| Biological Assay | 2 | 2023 | 628 | 0.110 |
Why?
|
| Myosin Type II | 1 | 2013 | 71 | 0.110 |
Why?
|
| Neoplastic Stem Cells | 1 | 2002 | 1351 | 0.110 |
Why?
|
| Pseudomonas aeruginosa | 1 | 2021 | 1276 | 0.110 |
Why?
|
| CHO Cells | 2 | 2015 | 1379 | 0.110 |
Why?
|
| Membranes, Artificial | 2 | 2011 | 367 | 0.110 |
Why?
|
| Absorption | 1 | 2013 | 244 | 0.110 |
Why?
|
| Fatty Acids, Unsaturated | 3 | 1992 | 542 | 0.110 |
Why?
|
| Bone Morphogenetic Protein 4 | 1 | 2014 | 163 | 0.110 |
Why?
|
| Sulfhydryl Compounds | 4 | 2002 | 296 | 0.110 |
Why?
|
| Proto-Oncogene Proteins c-met | 1 | 2017 | 564 | 0.110 |
Why?
|
| Cricetulus | 1 | 2015 | 812 | 0.110 |
Why?
|
| Bioengineering | 1 | 2014 | 101 | 0.110 |
Why?
|
| Tenascin | 1 | 2013 | 61 | 0.110 |
Why?
|
| Microtubule-Associated Proteins | 1 | 1998 | 1074 | 0.110 |
Why?
|
| Microscopy, Electron, Scanning | 3 | 2013 | 944 | 0.110 |
Why?
|
| Antibiotics, Antineoplastic | 3 | 1994 | 681 | 0.110 |
Why?
|
| Blotting, Western | 3 | 2011 | 5027 | 0.110 |
Why?
|
| Culture Media, Conditioned | 2 | 2013 | 521 | 0.110 |
Why?
|
| Lung Neoplasms | 3 | 2017 | 13586 | 0.110 |
Why?
|
| Coloring Agents | 2 | 2013 | 565 | 0.110 |
Why?
|
| Protein Unfolding | 1 | 2013 | 57 | 0.110 |
Why?
|
| Protein Structure, Tertiary | 5 | 2013 | 3772 | 0.110 |
Why?
|
| Cytochrome P-450 CYP3A | 1 | 2013 | 118 | 0.110 |
Why?
|
| Immune Tolerance | 1 | 2022 | 2323 | 0.110 |
Why?
|
| Platelet-Rich Plasma | 1 | 2016 | 180 | 0.110 |
Why?
|
| Optical Phenomena | 1 | 2013 | 104 | 0.110 |
Why?
|
| History, 20th Century | 1 | 2021 | 2766 | 0.100 |
Why?
|
| Hydrodynamics | 1 | 2014 | 167 | 0.100 |
Why?
|
| Hypertension, Pulmonary | 2 | 2008 | 1605 | 0.100 |
Why?
|
| Polymerization | 1 | 2013 | 155 | 0.100 |
Why?
|
| Heart Failure | 1 | 2017 | 11879 | 0.100 |
Why?
|
| Vaccines | 1 | 2021 | 842 | 0.100 |
Why?
|
| Interleukin-8 | 1 | 2015 | 704 | 0.100 |
Why?
|
| Drug Carriers | 1 | 2017 | 709 | 0.100 |
Why?
|
| Tubulin | 2 | 2003 | 695 | 0.100 |
Why?
|
| Stroke | 1 | 2015 | 9755 | 0.100 |
Why?
|
| Antibodies, Immobilized | 1 | 2012 | 22 | 0.100 |
Why?
|
| Myelin Proteins | 1 | 2013 | 212 | 0.100 |
Why?
|
| Mammary Neoplasms, Animal | 1 | 2013 | 123 | 0.100 |
Why?
|
| Feces | 1 | 2019 | 1511 | 0.100 |
Why?
|
| Pluripotent Stem Cells | 1 | 2019 | 809 | 0.100 |
Why?
|
| Proto-Oncogene Proteins | 4 | 2008 | 4528 | 0.100 |
Why?
|
| Bone Development | 1 | 2015 | 473 | 0.100 |
Why?
|
| Psoriasis | 1 | 2020 | 926 | 0.100 |
Why?
|
| Epigenesis, Genetic | 1 | 2006 | 3833 | 0.100 |
Why?
|
| Microarray Analysis | 1 | 2015 | 753 | 0.100 |
Why?
|
| Hemorheology | 1 | 2012 | 144 | 0.100 |
Why?
|
| Muscle, Smooth | 1 | 1996 | 931 | 0.100 |
Why?
|
| Area Under Curve | 1 | 2016 | 1643 | 0.100 |
Why?
|
| Neoplasm Proteins | 3 | 2022 | 3603 | 0.100 |
Why?
|
| Blood Coagulation | 1 | 2018 | 1162 | 0.100 |
Why?
|
| Gases | 1 | 2012 | 205 | 0.100 |
Why?
|
| Mesenteric Arteries | 1 | 2012 | 178 | 0.100 |
Why?
|
| Equipment and Supplies | 1 | 2014 | 274 | 0.100 |
Why?
|
| beta-Galactosidase | 2 | 2012 | 574 | 0.100 |
Why?
|
| Bone Marrow Transplantation | 1 | 2020 | 2709 | 0.100 |
Why?
|
| Fluorescein-5-isothiocyanate | 1 | 2012 | 221 | 0.100 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2015 | 693 | 0.100 |
Why?
|
| Central Nervous System Stimulants | 1 | 2020 | 1168 | 0.100 |
Why?
|
| Cell Count | 3 | 2011 | 1832 | 0.100 |
Why?
|
| Spectroscopy, Fourier Transform Infrared | 1 | 2011 | 161 | 0.100 |
Why?
|
| Enzyme Activation | 3 | 2005 | 3590 | 0.100 |
Why?
|
| Probiotics | 1 | 2015 | 387 | 0.100 |
Why?
|
| Membrane Proteins | 6 | 2011 | 7876 | 0.100 |
Why?
|
| Simian virus 40 | 1 | 2012 | 292 | 0.090 |
Why?
|
| Arterial Occlusive Diseases | 1 | 2015 | 744 | 0.090 |
Why?
|
| Catheters | 1 | 2014 | 427 | 0.090 |
Why?
|
| Aminopeptidases | 1 | 2012 | 114 | 0.090 |
Why?
|
| Blood Circulation | 1 | 2012 | 248 | 0.090 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 3 | 2007 | 2892 | 0.090 |
Why?
|
| Antigens, Polyomavirus Transforming | 1 | 2012 | 256 | 0.090 |
Why?
|
| Integrases | 1 | 2013 | 520 | 0.090 |
Why?
|
| Skin | 2 | 2020 | 4503 | 0.090 |
Why?
|
| Diphosphonates | 1 | 1996 | 634 | 0.090 |
Why?
|
| Angiopoietin-2 | 1 | 2012 | 186 | 0.090 |
Why?
|
| Tryptophan | 1 | 2013 | 482 | 0.090 |
Why?
|
| Up-Regulation | 3 | 2018 | 4146 | 0.090 |
Why?
|
| Muscle Fibers, Skeletal | 1 | 2014 | 553 | 0.090 |
Why?
|
| Phosphatidylinositol 3-Kinases | 4 | 2022 | 2885 | 0.090 |
Why?
|
| Enzyme Inhibitors | 3 | 2008 | 3728 | 0.090 |
Why?
|
| Metabolomics | 1 | 2020 | 1674 | 0.090 |
Why?
|
| Adenocarcinoma | 1 | 2008 | 6395 | 0.090 |
Why?
|
| Gene Products, env | 2 | 2002 | 250 | 0.090 |
Why?
|
| Blood Proteins | 1 | 2016 | 1191 | 0.090 |
Why?
|
| Drug Approval | 1 | 2018 | 821 | 0.090 |
Why?
|
| Myocardium | 2 | 2021 | 4788 | 0.090 |
Why?
|
| Immunohistochemistry | 5 | 2013 | 11095 | 0.090 |
Why?
|
| Doxorubicin | 1 | 2017 | 2234 | 0.090 |
Why?
|
| Pyridines | 3 | 2008 | 2894 | 0.090 |
Why?
|
| Biophysical Phenomena | 2 | 2004 | 320 | 0.090 |
Why?
|
| Alkaline Phosphatase | 1 | 2013 | 863 | 0.090 |
Why?
|
| Nuclear Matrix | 2 | 2004 | 30 | 0.090 |
Why?
|
| Mesenchymal Stem Cell Transplantation | 1 | 2015 | 507 | 0.090 |
Why?
|
| Protein Structure, Secondary | 1 | 2013 | 1216 | 0.090 |
Why?
|
| Structure-Activity Relationship | 2 | 2013 | 3055 | 0.080 |
Why?
|
| Biofilms | 1 | 2014 | 634 | 0.080 |
Why?
|
| Ozone | 1 | 2013 | 496 | 0.080 |
Why?
|
| Reactive Oxygen Species | 1 | 2018 | 2149 | 0.080 |
Why?
|
| Gene Knockdown Techniques | 2 | 2018 | 1606 | 0.080 |
Why?
|
| Air | 1 | 2010 | 187 | 0.080 |
Why?
|
| Interleukin-1beta | 1 | 2015 | 1027 | 0.080 |
Why?
|
| Polycyclic Compounds | 1 | 2009 | 28 | 0.080 |
Why?
|
| Chickens | 1 | 2011 | 845 | 0.080 |
Why?
|
| Neoplasm Seeding | 1 | 1989 | 85 | 0.080 |
Why?
|
| Vaccination | 1 | 2022 | 3437 | 0.080 |
Why?
|
| Software | 1 | 2003 | 4478 | 0.080 |
Why?
|
| Government Regulation | 1 | 2014 | 525 | 0.080 |
Why?
|
| Microscopy | 2 | 2012 | 909 | 0.080 |
Why?
|
| Silicon Dioxide | 1 | 2010 | 218 | 0.080 |
Why?
|
| Transcription Factors, TFII | 1 | 2009 | 62 | 0.080 |
Why?
|
| Ear | 2 | 2007 | 172 | 0.080 |
Why?
|
| Steroids | 3 | 1992 | 938 | 0.080 |
Why?
|
| Culture Media, Serum-Free | 2 | 2002 | 148 | 0.080 |
Why?
|
| Virus Replication | 1 | 2017 | 2458 | 0.080 |
Why?
|
| Recombinant Proteins | 6 | 2011 | 6514 | 0.080 |
Why?
|
| Immunologic Factors | 1 | 2018 | 1596 | 0.080 |
Why?
|
| Animals, Newborn | 2 | 2009 | 2678 | 0.080 |
Why?
|
| Talin | 3 | 2005 | 47 | 0.080 |
Why?
|
| False Positive Reactions | 2 | 2021 | 963 | 0.080 |
Why?
|
| Gene Knockout Techniques | 1 | 2011 | 806 | 0.080 |
Why?
|
| GATA2 Transcription Factor | 1 | 2009 | 158 | 0.080 |
Why?
|
| Models, Anatomic | 1 | 2012 | 680 | 0.080 |
Why?
|
| Proteoglycans | 1 | 2011 | 809 | 0.080 |
Why?
|
| Equipment Contamination | 1 | 1989 | 183 | 0.080 |
Why?
|
| Ultraviolet Rays | 1 | 2013 | 1103 | 0.080 |
Why?
|
| ROC Curve | 1 | 2016 | 3628 | 0.080 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 3 | 2009 | 1656 | 0.080 |
Why?
|
| Metagenome | 1 | 2012 | 465 | 0.070 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2023 | 3251 | 0.070 |
Why?
|
| Cell Surface Extensions | 1 | 2008 | 66 | 0.070 |
Why?
|
| Fibroblast Growth Factor 2 | 4 | 2011 | 590 | 0.070 |
Why?
|
| Pyrroles | 1 | 1994 | 1124 | 0.070 |
Why?
|
| Proto-Oncogene Proteins c-abl | 1 | 2008 | 145 | 0.070 |
Why?
|
| Wnt Proteins | 1 | 2012 | 725 | 0.070 |
Why?
|
| Isoquinolines | 1 | 2009 | 354 | 0.070 |
Why?
|
| Neutrophil Infiltration | 1 | 2010 | 393 | 0.070 |
Why?
|
| GTPase-Activating Proteins | 2 | 2008 | 467 | 0.070 |
Why?
|
| Adrenal Cortex | 3 | 1995 | 134 | 0.070 |
Why?
|
| High-Throughput Screening Assays | 1 | 2013 | 942 | 0.070 |
Why?
|
| Growth | 1 | 2009 | 366 | 0.070 |
Why?
|
| Single-Cell Analysis | 2 | 2021 | 2540 | 0.070 |
Why?
|
| Stress, Physiological | 1 | 2015 | 1408 | 0.070 |
Why?
|
| Liver Transplantation | 3 | 1994 | 2401 | 0.070 |
Why?
|
| Nonmuscle Myosin Type IIA | 1 | 2007 | 28 | 0.070 |
Why?
|
| Retinal Vessels | 2 | 2014 | 864 | 0.070 |
Why?
|
| Fibroblast Growth Factors | 3 | 1990 | 873 | 0.070 |
Why?
|
| Aorta | 2 | 2020 | 2045 | 0.070 |
Why?
|
| Heart, Artificial | 1 | 2007 | 110 | 0.070 |
Why?
|
| Homeostasis | 5 | 2003 | 3348 | 0.070 |
Why?
|
| Nerve Tissue Proteins | 2 | 2011 | 4413 | 0.070 |
Why?
|
| Hydroxycorticosteroids | 1 | 1986 | 3 | 0.070 |
Why?
|
| Surgical Instruments | 1 | 1989 | 381 | 0.070 |
Why?
|
| Osteogenesis | 1 | 2014 | 1288 | 0.070 |
Why?
|
| Plasmids | 1 | 2012 | 2269 | 0.070 |
Why?
|
| Receptors, G-Protein-Coupled | 2 | 2018 | 1247 | 0.070 |
Why?
|
| Hemodynamics | 2 | 2020 | 4194 | 0.070 |
Why?
|
| Nucleic Acid Conformation | 1 | 2010 | 899 | 0.070 |
Why?
|
| Mice, Knockout | 8 | 2016 | 14488 | 0.070 |
Why?
|
| Forecasting | 3 | 2009 | 2945 | 0.070 |
Why?
|
| Dose-Response Relationship, Drug | 5 | 2005 | 10760 | 0.070 |
Why?
|
| Bone Morphogenetic Proteins | 1 | 2012 | 845 | 0.070 |
Why?
|
| Glucose | 2 | 2020 | 4352 | 0.070 |
Why?
|
| Tissue Expansion | 1 | 2007 | 163 | 0.070 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 2 | 2006 | 615 | 0.070 |
Why?
|
| Microscopy, Video | 1 | 2006 | 241 | 0.070 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 1 | 2009 | 547 | 0.070 |
Why?
|
| Noise | 1 | 2008 | 295 | 0.060 |
Why?
|
| rac1 GTP-Binding Protein | 1 | 2007 | 246 | 0.060 |
Why?
|
| Biopsy | 1 | 2018 | 6793 | 0.060 |
Why?
|
| Phosphotyrosine | 2 | 1998 | 458 | 0.060 |
Why?
|
| Electromagnetic Phenomena | 1 | 2007 | 159 | 0.060 |
Why?
|
| Autoimmune Diseases | 1 | 2018 | 2257 | 0.060 |
Why?
|
| Integrin alpha4 | 1 | 2005 | 88 | 0.060 |
Why?
|
| Peptide Hydrolases | 2 | 2019 | 610 | 0.060 |
Why?
|
| Integrin alpha4beta1 | 1 | 2005 | 119 | 0.060 |
Why?
|
| Glycoproteins | 5 | 2018 | 2202 | 0.060 |
Why?
|
| Prostatic Neoplasms | 1 | 2008 | 11101 | 0.060 |
Why?
|
| Cyclooxygenase 2 | 1 | 2008 | 598 | 0.060 |
Why?
|
| Trypsin | 3 | 2003 | 491 | 0.060 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 2 | 2015 | 500 | 0.060 |
Why?
|
| Down-Regulation | 2 | 2019 | 2937 | 0.060 |
Why?
|
| Cell Compartmentation | 2 | 1998 | 383 | 0.060 |
Why?
|
| Fluorescence Resonance Energy Transfer | 1 | 2008 | 414 | 0.060 |
Why?
|
| Thrombopoiesis | 1 | 2007 | 166 | 0.060 |
Why?
|
| Dermis | 1 | 2006 | 203 | 0.060 |
Why?
|
| RNA Interference | 2 | 2016 | 2832 | 0.060 |
Why?
|
| Phosphoproteins | 4 | 2006 | 2451 | 0.060 |
Why?
|
| Vasoconstriction | 1 | 2008 | 592 | 0.060 |
Why?
|
| Evidence-Based Medicine | 1 | 2017 | 3706 | 0.060 |
Why?
|
| Models, Genetic | 1 | 2015 | 3447 | 0.060 |
Why?
|
| Base Sequence | 4 | 2010 | 12421 | 0.060 |
Why?
|
| Densitometry | 1 | 2005 | 151 | 0.060 |
Why?
|
| Vacuum | 1 | 2004 | 65 | 0.060 |
Why?
|
| Solubility | 1 | 2006 | 1083 | 0.060 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 1 | 2012 | 1627 | 0.060 |
Why?
|
| Carbon | 1 | 1988 | 673 | 0.060 |
Why?
|
| Cyclohexanes | 4 | 1994 | 151 | 0.060 |
Why?
|
| Alkanes | 2 | 2002 | 39 | 0.060 |
Why?
|
| Peptide Fragments | 3 | 2013 | 5151 | 0.060 |
Why?
|
| Light | 3 | 2006 | 1355 | 0.060 |
Why?
|
| Heparin | 6 | 1989 | 1636 | 0.060 |
Why?
|
| Epidermal Growth Factor | 2 | 1999 | 697 | 0.060 |
Why?
|
| Friction | 1 | 2004 | 59 | 0.060 |
Why?
|
| C-Reactive Protein | 1 | 2016 | 3858 | 0.060 |
Why?
|
| Carcinoma | 2 | 1986 | 2332 | 0.060 |
Why?
|
| Tunica Intima | 1 | 2006 | 459 | 0.060 |
Why?
|
| Vascular Neoplasms | 1 | 2005 | 167 | 0.060 |
Why?
|
| Dimethyl Sulfoxide | 1 | 2005 | 250 | 0.060 |
Why?
|
| Thrombin | 1 | 2006 | 600 | 0.060 |
Why?
|
| Mitochondria | 5 | 2005 | 3681 | 0.060 |
Why?
|
| Giant Cells | 2 | 2002 | 187 | 0.060 |
Why?
|
| Angioplasty | 1 | 2006 | 355 | 0.050 |
Why?
|
| Rotation | 1 | 2005 | 517 | 0.050 |
Why?
|
| Thrombospondin 1 | 1 | 2005 | 257 | 0.050 |
Why?
|
| Myosins | 1 | 2005 | 408 | 0.050 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2005 | 687 | 0.050 |
Why?
|
| Heart Transplantation | 1 | 2017 | 3301 | 0.050 |
Why?
|
| src-Family Kinases | 1 | 2006 | 539 | 0.050 |
Why?
|
| Intracellular Fluid | 1 | 2003 | 201 | 0.050 |
Why?
|
| Cell Communication | 2 | 2006 | 1660 | 0.050 |
Why?
|
| Microscopy, Atomic Force | 2 | 2019 | 250 | 0.050 |
Why?
|
| GTP-Binding Protein alpha Subunits, Gq-G11 | 1 | 2024 | 148 | 0.050 |
Why?
|
| Cell Fractionation | 1 | 2003 | 247 | 0.050 |
Why?
|
| Materials Testing | 1 | 2006 | 872 | 0.050 |
Why?
|
| Algorithms | 1 | 2003 | 14164 | 0.050 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 3115 | 0.050 |
Why?
|
| Mutation | 7 | 2012 | 30238 | 0.050 |
Why?
|
| Substrate Specificity | 1 | 2006 | 1751 | 0.050 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 3238 | 0.050 |
Why?
|
| Intermediate Filaments | 2 | 1993 | 171 | 0.050 |
Why?
|
| Chick Embryo | 3 | 1990 | 975 | 0.050 |
Why?
|
| Phenotype | 3 | 2019 | 16726 | 0.050 |
Why?
|
| Models, Statistical | 1 | 2017 | 5107 | 0.050 |
Why?
|
| Movement | 2 | 2021 | 1490 | 0.050 |
Why?
|
| Endothelin-1 | 2 | 2008 | 296 | 0.050 |
Why?
|
| Subcellular Fractions | 1 | 2003 | 525 | 0.050 |
Why?
|
| Luminescent Proteins | 2 | 2003 | 838 | 0.050 |
Why?
|
| Pancreatic Neoplasms | 5 | 1989 | 5446 | 0.050 |
Why?
|
| Tretinoin | 1 | 2005 | 524 | 0.050 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2006 | 633 | 0.050 |
Why?
|
| Gravity Sensing | 1 | 2021 | 5 | 0.050 |
Why?
|
| Metalloendopeptidases | 2 | 2000 | 386 | 0.050 |
Why?
|
| Systems Integration | 1 | 2003 | 430 | 0.050 |
Why?
|
| Agar | 1 | 2021 | 51 | 0.050 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2016 | 3252 | 0.050 |
Why?
|
| Endovascular Procedures | 1 | 2015 | 2216 | 0.050 |
Why?
|
| CDC2 Protein Kinase | 1 | 2002 | 212 | 0.050 |
Why?
|
| Genes, Neoplasm | 1 | 2003 | 371 | 0.050 |
Why?
|
| Bacteriological Techniques | 1 | 2022 | 277 | 0.050 |
Why?
|
| Cell Death | 1 | 2007 | 1679 | 0.050 |
Why?
|
| Genes, Dominant | 1 | 2004 | 855 | 0.050 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2009 | 3611 | 0.050 |
Why?
|
| Vesicular Transport Proteins | 1 | 2024 | 377 | 0.050 |
Why?
|
| Focal Adhesion Protein-Tyrosine Kinases | 2 | 2006 | 183 | 0.050 |
Why?
|
| Risk Assessment | 3 | 2018 | 24315 | 0.050 |
Why?
|
| Microinjections | 1 | 2002 | 321 | 0.050 |
Why?
|
| Binding Sites | 3 | 2002 | 6020 | 0.050 |
Why?
|
| Phospholipase C gamma | 2 | 2005 | 131 | 0.050 |
Why?
|
| Chemotaxis | 2 | 2021 | 600 | 0.050 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2022 | 505 | 0.050 |
Why?
|
| Drug Repositioning | 1 | 2023 | 246 | 0.050 |
Why?
|
| Stochastic Processes | 2 | 2015 | 360 | 0.040 |
Why?
|
| Rats, Sprague-Dawley | 3 | 2007 | 8128 | 0.040 |
Why?
|
| Simvastatin | 1 | 2023 | 346 | 0.040 |
Why?
|
| Gelatinases | 1 | 2000 | 93 | 0.040 |
Why?
|
| Hemangioma | 1 | 2005 | 727 | 0.040 |
Why?
|
| Adenosine Triphosphatases | 1 | 2005 | 842 | 0.040 |
Why?
|
| Type C Phospholipases | 2 | 2005 | 287 | 0.040 |
Why?
|
| Enzyme Precursors | 1 | 2000 | 166 | 0.040 |
Why?
|
| Models, Structural | 1 | 2000 | 340 | 0.040 |
Why?
|
| Peptidomimetics | 1 | 2020 | 31 | 0.040 |
Why?
|
| Surgical Wound Infection | 1 | 1989 | 1546 | 0.040 |
Why?
|
| Databases, Genetic | 2 | 2005 | 1758 | 0.040 |
Why?
|
| Music Therapy | 1 | 1982 | 111 | 0.040 |
Why?
|
| Cytosol | 1 | 2003 | 887 | 0.040 |
Why?
|
| Transferrin | 1 | 2021 | 283 | 0.040 |
Why?
|
| Hypotonic Solutions | 1 | 2019 | 48 | 0.040 |
Why?
|
| Vitronectin | 2 | 1997 | 40 | 0.040 |
Why?
|
| Retroviridae Proteins, Oncogenic | 1 | 1999 | 74 | 0.040 |
Why?
|
| Calcium-Binding Proteins | 1 | 2004 | 1083 | 0.040 |
Why?
|
| Molecular Structure | 2 | 2009 | 1883 | 0.040 |
Why?
|
| Atlases as Topic | 1 | 2021 | 248 | 0.040 |
Why?
|
| Electrochemistry | 1 | 1999 | 145 | 0.040 |
Why?
|
| Rats, Inbred F344 | 2 | 1994 | 826 | 0.040 |
Why?
|
| Umbilical Veins | 3 | 2009 | 424 | 0.040 |
Why?
|
| SNARE Proteins | 1 | 2019 | 80 | 0.040 |
Why?
|
| Caveolins | 1 | 2019 | 102 | 0.040 |
Why?
|
| Phagocytes | 1 | 2021 | 294 | 0.040 |
Why?
|
| Kupffer Cells | 1 | 2019 | 143 | 0.040 |
Why?
|
| Gestational Age | 2 | 2013 | 3621 | 0.040 |
Why?
|
| Actomyosin | 2 | 2006 | 114 | 0.040 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2009 | 2056 | 0.040 |
Why?
|
| Microcirculation | 2 | 2018 | 1281 | 0.040 |
Why?
|
| Neoplasm Transplantation | 3 | 2014 | 2014 | 0.040 |
Why?
|
| Magnesium Chloride | 1 | 1998 | 30 | 0.040 |
Why?
|
| Octoxynol | 1 | 1998 | 76 | 0.040 |
Why?
|
| Oxidative Stress | 1 | 2010 | 3139 | 0.040 |
Why?
|
| Nitric Oxide | 1 | 2008 | 2146 | 0.040 |
Why?
|
| Physical Stimulation | 1 | 2000 | 517 | 0.040 |
Why?
|
| Flavonoids | 1 | 2002 | 447 | 0.040 |
Why?
|
| Feedback, Physiological | 1 | 2021 | 482 | 0.040 |
Why?
|
| Genes, Reporter | 1 | 2003 | 1524 | 0.040 |
Why?
|
| Protease Inhibitors | 1 | 2022 | 751 | 0.040 |
Why?
|
| Antibodies, Monoclonal | 1 | 2016 | 9263 | 0.040 |
Why?
|
| Phosphatidylinositol 4,5-Diphosphate | 2 | 1996 | 123 | 0.040 |
Why?
|
| Adenoviridae | 1 | 2003 | 1092 | 0.040 |
Why?
|
| Neoplasm Staging | 1 | 2013 | 11244 | 0.040 |
Why?
|
| Retinoblastoma Protein | 1 | 2002 | 671 | 0.040 |
Why?
|
| Matrix Metalloproteinase 2 | 1 | 2000 | 461 | 0.040 |
Why?
|
| Dibutyryl Cyclic GMP | 1 | 1998 | 6 | 0.040 |
Why?
|
| Boston | 1 | 2011 | 9374 | 0.040 |
Why?
|
| Myosin-Light-Chain Kinase | 1 | 1998 | 104 | 0.040 |
Why?
|
| Ionomycin | 1 | 1998 | 110 | 0.040 |
Why?
|
| Synapses | 1 | 2007 | 1765 | 0.040 |
Why?
|
| Detergents | 1 | 1998 | 235 | 0.040 |
Why?
|
| Reference Standards | 1 | 2021 | 1014 | 0.040 |
Why?
|
| Endocytosis | 2 | 2018 | 956 | 0.040 |
Why?
|
| Poly A | 1 | 1998 | 180 | 0.040 |
Why?
|
| Fetus | 1 | 2005 | 1883 | 0.040 |
Why?
|
| Allantois | 2 | 1988 | 32 | 0.040 |
Why?
|
| Silicones | 2 | 2000 | 228 | 0.040 |
Why?
|
| Primates | 1 | 2020 | 520 | 0.040 |
Why?
|
| Hydrogen-Ion Concentration | 3 | 1991 | 2486 | 0.040 |
Why?
|
| rab GTP-Binding Proteins | 1 | 2019 | 247 | 0.040 |
Why?
|
| Chemistry, Physical | 1 | 1997 | 153 | 0.040 |
Why?
|
| Osmolar Concentration | 1 | 1998 | 657 | 0.040 |
Why?
|
| Protein Transport | 2 | 2019 | 1951 | 0.040 |
Why?
|
| Medical Records | 1 | 2023 | 1410 | 0.040 |
Why?
|
| Vimentin | 1 | 1998 | 257 | 0.040 |
Why?
|
| Poaceae | 1 | 2017 | 25 | 0.040 |
Why?
|
| RNA, Transfer | 1 | 1999 | 284 | 0.040 |
Why?
|
| Chorion | 2 | 1988 | 113 | 0.040 |
Why?
|
| Predatory Behavior | 1 | 2017 | 26 | 0.040 |
Why?
|
| Autopsy | 1 | 2021 | 1011 | 0.040 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 1 | 1998 | 492 | 0.040 |
Why?
|
| Silver | 1 | 1997 | 119 | 0.030 |
Why?
|
| Factor Xa | 1 | 2018 | 166 | 0.030 |
Why?
|
| Acrylamide | 1 | 1997 | 59 | 0.030 |
Why?
|
| Bioreactors | 1 | 1998 | 246 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-akt | 2 | 2005 | 2457 | 0.030 |
Why?
|
| Leucine | 2 | 2015 | 547 | 0.030 |
Why?
|
| Endosomes | 1 | 2019 | 522 | 0.030 |
Why?
|
| Radiation Dosage | 1 | 2005 | 1967 | 0.030 |
Why?
|
| Molecular Diagnostic Techniques | 1 | 2021 | 620 | 0.030 |
Why?
|
| Viruses | 1 | 2020 | 373 | 0.030 |
Why?
|
| Placenta | 1 | 2005 | 1725 | 0.030 |
Why?
|
| Catalysis | 1 | 1998 | 768 | 0.030 |
Why?
|
| Serine | 1 | 2020 | 831 | 0.030 |
Why?
|
| Sodium Chloride | 1 | 1998 | 584 | 0.030 |
Why?
|
| Transcriptional Activation | 2 | 2006 | 1750 | 0.030 |
Why?
|
| Engineering | 1 | 1996 | 56 | 0.030 |
Why?
|
| Urokinase-Type Plasminogen Activator | 1 | 1997 | 324 | 0.030 |
Why?
|
| Photography | 1 | 1999 | 537 | 0.030 |
Why?
|
| Plasminogen Activator Inhibitor 1 | 1 | 1997 | 279 | 0.030 |
Why?
|
| Serine Proteinase Inhibitors | 1 | 1997 | 174 | 0.030 |
Why?
|
| Transplantation, Isogeneic | 2 | 1994 | 249 | 0.030 |
Why?
|
| Angiogenesis Inducing Agents | 2 | 1988 | 254 | 0.030 |
Why?
|
| Plants | 1 | 2017 | 332 | 0.030 |
Why?
|
| Mesonephros | 1 | 2015 | 42 | 0.030 |
Why?
|
| Nerve Net | 1 | 2007 | 2352 | 0.030 |
Why?
|
| Focal Adhesion Kinase 1 | 1 | 1995 | 120 | 0.030 |
Why?
|
| Biological Specimen Banks | 1 | 2021 | 788 | 0.030 |
Why?
|
| Proto-Oncogene Proteins pp60(c-src) | 1 | 1995 | 147 | 0.030 |
Why?
|
| Water | 1 | 2021 | 1421 | 0.030 |
Why?
|
| Protein Kinases | 1 | 2002 | 1611 | 0.030 |
Why?
|
| Surface Tension | 1 | 2015 | 43 | 0.030 |
Why?
|
| Viral Load | 2 | 2021 | 3396 | 0.030 |
Why?
|
| Hot Temperature | 1 | 2021 | 1441 | 0.030 |
Why?
|
| Thermodynamics | 1 | 1997 | 591 | 0.030 |
Why?
|
| Acrylamides | 1 | 1997 | 261 | 0.030 |
Why?
|
| Nephrectomy | 1 | 2020 | 930 | 0.030 |
Why?
|
| Bayes Theorem | 1 | 2023 | 2359 | 0.030 |
Why?
|
| Photic Stimulation | 1 | 2021 | 1997 | 0.030 |
Why?
|
| Alendronate | 1 | 1996 | 174 | 0.030 |
Why?
|
| Mice, Mutant Strains | 2 | 2008 | 1754 | 0.030 |
Why?
|
| Receptors, IgG | 1 | 2018 | 564 | 0.030 |
Why?
|
| Leukocytes | 2 | 2009 | 2035 | 0.030 |
Why?
|
| Dogs | 1 | 2019 | 3845 | 0.030 |
Why?
|
| Endothelial Growth Factors | 2 | 1987 | 671 | 0.030 |
Why?
|
| Reference Values | 1 | 2021 | 4938 | 0.030 |
Why?
|
| Cellulose | 1 | 1994 | 117 | 0.030 |
Why?
|
| Spectrophotometry, Ultraviolet | 1 | 1994 | 199 | 0.030 |
Why?
|
| Interleukin-17 | 1 | 2020 | 924 | 0.030 |
Why?
|
| Cardiomegaly | 1 | 1997 | 591 | 0.030 |
Why?
|
| Treatment Failure | 1 | 2020 | 2661 | 0.030 |
Why?
|
| HIV-1 | 2 | 2002 | 6961 | 0.030 |
Why?
|
| Paclitaxel | 2 | 2006 | 1733 | 0.030 |
Why?
|
| Colony Count, Microbial | 1 | 2014 | 328 | 0.030 |
Why?
|
| Finite Element Analysis | 2 | 2007 | 441 | 0.030 |
Why?
|
| E-Selectin | 1 | 1996 | 577 | 0.030 |
Why?
|
| Cell Dedifferentiation | 1 | 2014 | 125 | 0.030 |
Why?
|
| Electric Stimulation | 1 | 2019 | 1741 | 0.030 |
Why?
|
| Polyvinyls | 1 | 1994 | 154 | 0.030 |
Why?
|
| Toxicity Tests | 1 | 2014 | 114 | 0.030 |
Why?
|
| Drug Industry | 1 | 2020 | 791 | 0.030 |
Why?
|
| Mitosis | 1 | 1998 | 1178 | 0.030 |
Why?
|
| Wound Healing | 1 | 2004 | 2809 | 0.030 |
Why?
|
| Child | 2 | 2022 | 80917 | 0.030 |
Why?
|
| Computational Biology | 1 | 2005 | 3568 | 0.030 |
Why?
|
| Glioma | 1 | 2008 | 3503 | 0.030 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 1 | 1995 | 434 | 0.030 |
Why?
|
| Genetic Vectors | 1 | 2003 | 3402 | 0.030 |
Why?
|
| Solutions | 1 | 1993 | 409 | 0.030 |
Why?
|
| HeLa Cells | 3 | 2006 | 3074 | 0.030 |
Why?
|
| Embryonic and Fetal Development | 1 | 1994 | 420 | 0.030 |
Why?
|
| Epoxide Hydrolases | 1 | 2013 | 122 | 0.030 |
Why?
|
| Reproduction | 1 | 2017 | 646 | 0.030 |
Why?
|
| Adult | 3 | 2023 | 223646 | 0.030 |
Why?
|
| Transforming Growth Factor beta | 1 | 2020 | 1996 | 0.020 |
Why?
|
| Evaluation Studies as Topic | 1 | 1994 | 1627 | 0.020 |
Why?
|
| Microbial Collagenase | 1 | 1992 | 112 | 0.020 |
Why?
|
| Sulfones | 1 | 1994 | 448 | 0.020 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2002 | 2954 | 0.020 |
Why?
|
| Platelet Factor 4 | 1 | 1992 | 132 | 0.020 |
Why?
|
| Video Recording | 1 | 1997 | 976 | 0.020 |
Why?
|
| Amiloride | 1 | 1991 | 116 | 0.020 |
Why?
|
| Pandemics | 2 | 2022 | 8748 | 0.020 |
Why?
|
| Blood Flow Velocity | 1 | 2015 | 1375 | 0.020 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 1989 | 9419 | 0.020 |
Why?
|
| Electrophysiology | 1 | 1994 | 1266 | 0.020 |
Why?
|
| Infant, Newborn | 2 | 2013 | 26422 | 0.020 |
Why?
|
| Liver Diseases | 1 | 2019 | 1305 | 0.020 |
Why?
|
| Isoenzymes | 1 | 1995 | 1688 | 0.020 |
Why?
|
| Protein Biosynthesis | 1 | 1998 | 2094 | 0.020 |
Why?
|
| Muscle, Skeletal | 2 | 2014 | 4978 | 0.020 |
Why?
|
| Aryl Hydrocarbon Hydroxylases | 1 | 2011 | 246 | 0.020 |
Why?
|
| Growth Hormone | 1 | 1993 | 573 | 0.020 |
Why?
|
| Exercise Tolerance | 1 | 2016 | 846 | 0.020 |
Why?
|
| Mice, Inbred C3H | 1 | 1991 | 915 | 0.020 |
Why?
|
| Chemical Phenomena | 1 | 2010 | 486 | 0.020 |
Why?
|
| Calpain | 1 | 2010 | 146 | 0.020 |
Why?
|
| Cell Hypoxia | 1 | 2012 | 662 | 0.020 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2020 | 2909 | 0.020 |
Why?
|
| Cycloheximide | 1 | 1989 | 341 | 0.020 |
Why?
|
| Adenoma, Islet Cell | 1 | 1989 | 72 | 0.020 |
Why?
|
| Chromatography, Liquid | 1 | 2013 | 996 | 0.020 |
Why?
|
| Aspergillus fumigatus | 1 | 1990 | 158 | 0.020 |
Why?
|
| Viscoelastic Substances | 1 | 2009 | 21 | 0.020 |
Why?
|
| Eye | 1 | 2013 | 712 | 0.020 |
Why?
|
| Cytochrome P-450 Enzyme System | 1 | 2011 | 423 | 0.020 |
Why?
|
| Protein Conformation | 2 | 2008 | 3956 | 0.020 |
Why?
|
| Receptors, Immunologic | 1 | 1995 | 1418 | 0.020 |
Why?
|
| Cortisone | 1 | 1989 | 90 | 0.020 |
Why?
|
| Macrophages | 1 | 2024 | 5799 | 0.020 |
Why?
|
| Bronchial Spasm | 1 | 2009 | 71 | 0.020 |
Why?
|
| Aminopropionitrile | 1 | 1988 | 9 | 0.020 |
Why?
|
| Rats, Inbred Strains | 2 | 1991 | 2087 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2018 | 4283 | 0.020 |
Why?
|
| Receptors, Fibronectin | 1 | 2008 | 37 | 0.020 |
Why?
|
| Pneumonectomy | 1 | 2016 | 1156 | 0.020 |
Why?
|
| Iloprost | 1 | 2008 | 25 | 0.020 |
Why?
|
| Host-Pathogen Interactions | 1 | 2017 | 1469 | 0.020 |
Why?
|
| Receptor, Endothelin A | 1 | 2008 | 55 | 0.020 |
Why?
|
| Sodium Channels | 1 | 1990 | 341 | 0.020 |
Why?
|
| Zebrafish | 1 | 2020 | 3035 | 0.020 |
Why?
|
| Protein Denaturation | 1 | 2008 | 242 | 0.020 |
Why?
|
| Acclimatization | 1 | 2008 | 113 | 0.020 |
Why?
|
| Traction | 1 | 2008 | 112 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 2010 | 637 | 0.020 |
Why?
|
| Interferon-alpha | 1 | 1992 | 910 | 0.020 |
Why?
|
| Hypertrophy, Right Ventricular | 1 | 2008 | 109 | 0.020 |
Why?
|
| Aged | 2 | 2021 | 171504 | 0.020 |
Why?
|
| United States | 2 | 2014 | 73039 | 0.020 |
Why?
|
| Blood Pressure | 2 | 2008 | 8543 | 0.020 |
Why?
|
| Cartilage | 1 | 1991 | 811 | 0.020 |
Why?
|
| Solvents | 1 | 2008 | 298 | 0.020 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 1999 | 2195 | 0.020 |
Why?
|
| Antigens, Ly | 1 | 2008 | 297 | 0.020 |
Why?
|
| Transcription Factor Pit-1 | 1 | 2006 | 16 | 0.020 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 1 | 2007 | 180 | 0.020 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2013 | 1197 | 0.020 |
Why?
|
| GATA1 Transcription Factor | 1 | 2008 | 306 | 0.020 |
Why?
|
| Macromolecular Substances | 2 | 2002 | 1435 | 0.020 |
Why?
|
| Gels | 1 | 2008 | 423 | 0.020 |
Why?
|
| Musculoskeletal System | 1 | 2009 | 188 | 0.020 |
Why?
|
| Veins | 1 | 1991 | 769 | 0.020 |
Why?
|
| Proline | 1 | 1988 | 455 | 0.020 |
Why?
|
| Erythroid Cells | 1 | 2008 | 237 | 0.020 |
Why?
|
| Pancreas | 2 | 1985 | 1700 | 0.020 |
Why?
|
| Excitatory Postsynaptic Potentials | 1 | 2007 | 369 | 0.020 |
Why?
|
| Population Dynamics | 1 | 2008 | 314 | 0.020 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 1995 | 2433 | 0.020 |
Why?
|
| Mucoproteins | 1 | 2005 | 49 | 0.020 |
Why?
|
| Leukemia | 1 | 2014 | 1519 | 0.020 |
Why?
|
| Middle Aged | 2 | 2021 | 223492 | 0.020 |
Why?
|
| 17-Hydroxysteroid Dehydrogenases | 1 | 2005 | 58 | 0.020 |
Why?
|
| Nuclear Magnetic Resonance, Biomolecular | 1 | 2009 | 506 | 0.020 |
Why?
|
| Endopeptidases | 1 | 1989 | 764 | 0.020 |
Why?
|
| Stem Cell Transplantation | 1 | 2014 | 1596 | 0.020 |
Why?
|
| Carotid Artery Injuries | 1 | 2006 | 96 | 0.020 |
Why?
|
| Microvilli | 1 | 1986 | 235 | 0.020 |
Why?
|
| Recovery of Function | 1 | 2016 | 2981 | 0.020 |
Why?
|
| Mice, SCID | 1 | 2010 | 2627 | 0.020 |
Why?
|
| Patch-Clamp Techniques | 1 | 2007 | 927 | 0.020 |
Why?
|
| United States Food and Drug Administration | 1 | 2014 | 1673 | 0.020 |
Why?
|
| Sulfonamides | 1 | 2015 | 1982 | 0.020 |
Why?
|
| Antigens, CD | 1 | 1995 | 4035 | 0.020 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2006 | 432 | 0.020 |
Why?
|
| Dendrites | 1 | 2007 | 472 | 0.020 |
Why?
|
| Clone Cells | 1 | 2008 | 1670 | 0.010 |
Why?
|
| Amnion | 1 | 1986 | 204 | 0.010 |
Why?
|
| Adrenal Glands | 1 | 1987 | 557 | 0.010 |
Why?
|
| Prolactin | 1 | 2006 | 627 | 0.010 |
Why?
|
| COS Cells | 1 | 2006 | 1135 | 0.010 |
Why?
|
| Protein Folding | 1 | 2008 | 871 | 0.010 |
Why?
|
| Jurkat Cells | 1 | 2005 | 740 | 0.010 |
Why?
|
| Cornea | 2 | 1991 | 1316 | 0.010 |
Why?
|
| Neural Inhibition | 1 | 2007 | 588 | 0.010 |
Why?
|
| Vasodilator Agents | 1 | 2008 | 990 | 0.010 |
Why?
|
| Combined Modality Therapy | 1 | 2015 | 8542 | 0.010 |
Why?
|
| Crystallography, X-Ray | 1 | 2008 | 1951 | 0.010 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 1 | 2005 | 693 | 0.010 |
Why?
|
| Immunoblotting | 1 | 2006 | 1647 | 0.010 |
Why?
|
| Fluorescence Polarization | 1 | 2003 | 139 | 0.010 |
Why?
|
| Cerebrovascular Circulation | 1 | 2013 | 2725 | 0.010 |
Why?
|
| Megakaryocytes | 1 | 2007 | 571 | 0.010 |
Why?
|
| Immunoglobulins | 1 | 2005 | 855 | 0.010 |
Why?
|
| Microscopy, Electron | 1 | 1986 | 2560 | 0.010 |
Why?
|
| Neoplasm Invasiveness | 1 | 2010 | 3620 | 0.010 |
Why?
|
| Environment | 1 | 2008 | 1121 | 0.010 |
Why?
|
| Precancerous Conditions | 1 | 1989 | 985 | 0.010 |
Why?
|
| Phosphoserine | 1 | 2002 | 204 | 0.010 |
Why?
|
| RNA Polymerase II | 1 | 2006 | 549 | 0.010 |
Why?
|
| Indicators and Reagents | 1 | 2003 | 456 | 0.010 |
Why?
|
| Nanomedicine | 1 | 2005 | 292 | 0.010 |
Why?
|
| Ryanodine Receptor Calcium Release Channel | 1 | 2003 | 185 | 0.010 |
Why?
|
| Genome-Wide Association Study | 1 | 2021 | 12795 | 0.010 |
Why?
|
| Tissue Distribution | 1 | 2005 | 2300 | 0.010 |
Why?
|
| Protein Isoforms | 1 | 2006 | 1715 | 0.010 |
Why?
|
| Thiazolidines | 1 | 2001 | 70 | 0.010 |
Why?
|
| Cardiovascular System | 1 | 2009 | 841 | 0.010 |
Why?
|
| Synaptic Transmission | 1 | 2007 | 1177 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2019 | 20227 | 0.010 |
Why?
|
| Nuclear Envelope | 1 | 2002 | 163 | 0.010 |
Why?
|
| gamma-Aminobutyric Acid | 1 | 2007 | 1141 | 0.010 |
Why?
|
| bcl-2-Associated X Protein | 1 | 2002 | 281 | 0.010 |
Why?
|
| Gene Expression | 1 | 2014 | 7598 | 0.010 |
Why?
|
| Catheterization | 1 | 2006 | 1430 | 0.010 |
Why?
|
| Membrane Fusion | 1 | 2002 | 265 | 0.010 |
Why?
|
| Immunophenotyping | 1 | 2005 | 1864 | 0.010 |
Why?
|
| Vascular Diseases | 1 | 2009 | 1162 | 0.010 |
Why?
|
| Diffusion Chambers, Culture | 1 | 2000 | 49 | 0.010 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2006 | 2521 | 0.010 |
Why?
|
| Oncogene Proteins v-raf | 1 | 1999 | 3 | 0.010 |
Why?
|
| Culture Techniques | 1 | 2000 | 530 | 0.010 |
Why?
|
| Embryonic Stem Cells | 1 | 2007 | 1250 | 0.010 |
Why?
|
| Insulin | 1 | 1994 | 6607 | 0.010 |
Why?
|
| DNA Replication | 1 | 1987 | 1427 | 0.010 |
Why?
|
| Silicon | 1 | 2000 | 143 | 0.010 |
Why?
|
| Sex Factors | 1 | 2013 | 10632 | 0.010 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 1 | 1989 | 1437 | 0.010 |
Why?
|
| Calcium Channels | 1 | 2003 | 623 | 0.010 |
Why?
|
| Razoxane | 1 | 1978 | 43 | 0.010 |
Why?
|
| Cluster Analysis | 1 | 2005 | 2732 | 0.010 |
Why?
|
| Trans-Activators | 1 | 2008 | 2857 | 0.010 |
Why?
|
| GTP-Binding Proteins | 1 | 2003 | 948 | 0.010 |
Why?
|
| Hydrolysis | 1 | 1999 | 646 | 0.010 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 1999 | 826 | 0.010 |
Why?
|
| Retina | 1 | 2009 | 2662 | 0.010 |
Why?
|
| Caffeine | 1 | 2003 | 703 | 0.010 |
Why?
|
| Brain Neoplasms | 1 | 2019 | 9118 | 0.010 |
Why?
|
| Receptors, CXCR4 | 1 | 2002 | 729 | 0.010 |
Why?
|
| Receptors, Vitronectin | 1 | 1997 | 48 | 0.010 |
Why?
|
| Enzymes, Immobilized | 1 | 1997 | 53 | 0.010 |
Why?
|
| Receptors, Urokinase Plasminogen Activator | 1 | 1997 | 75 | 0.010 |
Why?
|
| Myocytes, Cardiac | 1 | 2006 | 1681 | 0.010 |
Why?
|
| Blood | 1 | 1999 | 599 | 0.010 |
Why?
|
| Plasminogen Activators | 1 | 1997 | 199 | 0.010 |
Why?
|
| Microchemistry | 1 | 1996 | 55 | 0.010 |
Why?
|
| DNA, Complementary | 1 | 1999 | 1989 | 0.010 |
Why?
|
| Integrin alpha2 | 1 | 1995 | 39 | 0.010 |
Why?
|
| Heterozygote | 1 | 2003 | 2798 | 0.010 |
Why?
|
| RNA | 1 | 2005 | 2720 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2021 | 59629 | 0.010 |
Why?
|
| Kidney Diseases | 1 | 2006 | 2100 | 0.010 |
Why?
|
| Cats | 1 | 1997 | 978 | 0.010 |
Why?
|
| Gelsolin | 1 | 1995 | 189 | 0.010 |
Why?
|
| DNA Primers | 1 | 1999 | 2828 | 0.010 |
Why?
|
| Promoter Regions, Genetic | 1 | 2006 | 5797 | 0.010 |
Why?
|
| Hippocampus | 1 | 2007 | 3785 | 0.010 |
Why?
|
| Fluorescent Dyes | 1 | 2003 | 1930 | 0.010 |
Why?
|
| Titanium | 1 | 1997 | 495 | 0.010 |
Why?
|
| Thymidine | 1 | 1994 | 297 | 0.010 |
Why?
|
| Antiretroviral Therapy, Highly Active | 1 | 2002 | 1903 | 0.010 |
Why?
|
| Thiazoles | 1 | 2001 | 1542 | 0.010 |
Why?
|
| Uridine | 1 | 1994 | 135 | 0.010 |
Why?
|
| Peptides, Cyclic | 1 | 1995 | 391 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2018 | 54926 | 0.010 |
Why?
|
| Photomicrography | 1 | 1993 | 71 | 0.010 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2002 | 2062 | 0.010 |
Why?
|
| Chronic Disease | 1 | 2008 | 9384 | 0.010 |
Why?
|
| Methacrylates | 1 | 1993 | 110 | 0.010 |
Why?
|
| Antigens, Surface | 1 | 1997 | 1617 | 0.010 |
Why?
|
| Polyvinyl Alcohol | 1 | 1993 | 74 | 0.010 |
Why?
|
| Risk Factors | 1 | 2019 | 74944 | 0.010 |
Why?
|
| Blotting, Southern | 1 | 1993 | 775 | 0.010 |
Why?
|
| Diagnostic Imaging | 1 | 2006 | 3533 | 0.010 |
Why?
|
| Interleukin-1 | 1 | 1996 | 1252 | 0.010 |
Why?
|
| Lactates | 1 | 1993 | 401 | 0.010 |
Why?
|
| Rats, Inbred Lew | 1 | 1993 | 1162 | 0.010 |
Why?
|
| Polyesters | 1 | 1993 | 377 | 0.010 |
Why?
|
| Biodegradation, Environmental | 1 | 1991 | 220 | 0.010 |
Why?
|
| Retroviridae | 1 | 1993 | 846 | 0.010 |
Why?
|
| Mercury | 1 | 1993 | 289 | 0.010 |
Why?
|
| Asthma | 1 | 2009 | 6291 | 0.010 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2002 | 4415 | 0.010 |
Why?
|
| Bacterial Proteins | 1 | 2003 | 3840 | 0.010 |
Why?
|
| Cell Transplantation | 1 | 1991 | 475 | 0.000 |
Why?
|
| Retrospective Studies | 1 | 2018 | 81762 | 0.000 |
Why?
|
| Treatment Outcome | 1 | 2015 | 65371 | 0.000 |
Why?
|
| Protein Kinase C | 1 | 1993 | 1207 | 0.000 |
Why?
|
| Piperazines | 1 | 1978 | 2554 | 0.000 |
Why?
|
| Descemet Membrane | 1 | 1988 | 70 | 0.000 |
Why?
|
| Chromatography, Affinity | 1 | 1988 | 525 | 0.000 |
Why?
|
| Prostheses and Implants | 1 | 1993 | 1276 | 0.000 |
Why?
|
| Hyperplasia | 1 | 1989 | 1151 | 0.000 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 1988 | 1730 | 0.000 |
Why?
|
| Remission Induction | 1 | 1989 | 2410 | 0.000 |
Why?
|
| Oncogenes | 1 | 1989 | 1234 | 0.000 |
Why?
|
| Receptors, Mitogen | 1 | 1981 | 61 | 0.000 |
Why?
|
| Glycogen | 1 | 1981 | 252 | 0.000 |
Why?
|
| Melanoma | 1 | 1978 | 5706 | 0.000 |
Why?
|
| Guinea Pigs | 1 | 1981 | 1310 | 0.000 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 1989 | 3780 | 0.000 |
Why?
|
| Ferritins | 1 | 1981 | 601 | 0.000 |
Why?
|
| HIV Infections | 1 | 2002 | 17569 | 0.000 |
Why?
|
| Glycosaminoglycans | 1 | 1978 | 611 | 0.000 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 1987 | 2333 | 0.000 |
Why?
|
| Liver Neoplasms | 1 | 1987 | 4362 | 0.000 |
Why?
|